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ABSTRACT 
Equilibrium unfolding, single- and double-jump kinetic studies were conducted to 
determine the unfolding and refolding pathway of glutaredoxin 2. Structural 
changes for wild-type glutaredoxin 2 were monitored by far-ultraviolet circular 
dichroism and intrinsic tryptophan fluorescence for equilibrium unfolding and 
intrinsic tryptophan fluorescence for single- and double-jump kinetics studies. 
Glutaredoxin 2 possesses two tryptophan residues in domain 2. In order to 
monitor changes in domain 1, cysteine 9 at the active site cysteines, situated in 
domain 1, was labelled with an extrinsic fluorophore, AEDANS, and a mutant 
was created (Y58W glutaredoxin 2). The AEDANS labelled protein displayed 
decreased alpha-helical secondary structure and conformational stability. A high 
degree of cooperativity and similar conformational stability was observed during 
the two-state transition of the urea-induced equilibrium unfolding of both the 
wild-type and Y58W glutaredoxin 2 proteins therefore Y58W glutaredoxin 2 
could be used to assess structural changes in the local environment of domain 1 
during unfolding and refolding. Two phases of unfolding, the fast and slow phase, 
occurred for both the wild-type and Y58W proteins. The slow phase involves 
structural rearrangements that expose small amounts of surface area while the fast 
phase represents gross structural unfolding exposing large amounts of surface 
area. The isomerization of the Val48-Pro49 peptide bond to the trans 
conformation occurs during the slow phase and this isomerization is coupled to 
conformational unfolding of the protein. The structural separation of these phases 
could be represented by two structural units (unit x and unit y), these units do not 
represent domain 1 and 2. The units could also result in parallel refolding 
pathways with the folding of the x unit involving the fast and slow refolding 
phases and the folding of the y unit of structure is represented by the medium 
phase of refolding. The fast and slow phases are further separated as the fast 
phase represents the gross structural folding of glutaredoxin 2 for species with the 
Val48-Pro49 peptide bond in the native cis conformation. The development of the 
slow phase after extended unfolding delay periods during double-jump refolding 
studies, as well as the acceleration of the rate of the phase by the peptidyl prolyl 
isomerase hFKBP-12 proved that the phase involves a proline peptide bond 
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isomerization. This phase represents a slow isomerization coupled with 
conformational folding similar to the slow unfolding phase. Complex unfolding 
and refolding kinetics indicated the involvement of kinetic intermediates during 
(un)folding. 
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1 INTRODUCTION 
1.1 Protein folding: a general introduction 
Proteins are synthesised according to the Central Dogma: 
DNA›RNA›protein, once synthesised these linear polypeptide chains adopt 
unique three-dimensional structures. The process by which these polypeptides 
obtain their unique structures is termed protein folding and the ‘protein folding 
problem’ refers to the question as to how these linear sequences adopt their native 
structures. In addressing this problem, Anfinsen (1973) demonstrated that the 
amino acid sequence contains all the information to specify the final fully 
functional 3–dimensional structure of the protein. The exact mechanism as to how 
the unique sequence of amino acids dictated the final structure is not fully 
understood. What is understood is that the time it takes for proteins to fold 
dictates that proteins do not attain their native structure by a random process 
(Levinthal, 1968) but are rather said to pass through a limited number of states 
along a defined pathway to the native state (Creighton, 1990; Jaenicke, 1991; 
Schmid, 1992). 
 
1.1.1 Some protein folding models 
In order to understand and explain how proteins fold, many folding models have 
been proposed. These models aim to generalize protein folding mechanisms so 
that one model could explain any protein’s folding behaviour in the time frame at 
which folding occurs. One such model is the hydrophobic collapse model, this 
model identifies the first step in folding to be collapse of the polypeptide chain by 
long range hydrophobic interactions (Dill, 1985). In the hydrophobic collapse 
model the hydrophobic collapse occurs prior to any secondary structure formation 
however it has been accepted and Dill an co-workers later proposed that instead 
local secondary structure forms simultaneously with the collapse of the 
polypeptide during folding. The diffusion-collision model builds on this and 
proposes that small microdomains form early during folding, these microdomains 
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are made up of secondary structural elements (Karplus and Weaver, 1994). 
Folding then continues with the microdomains interacting to form 
multimicrodomain intermediates, these multimicrodomain elements form and 
disappear until the tertiary structure is formed (Karplus and Weaver, 1994). The 
last phase of folding is the formation of the tertiary structural elements and the 
correct packing of the side chains. It is also during this phase that slow rate-
limiting steps such as proline isomerization occurs (Karplus and Weaver, 1994).  
 
A model that is based on the classical nucleation model and expands on the 
diffusion-collision model, is the nucleation-condensation model (Fersht, 1997). In 
this model there is a larger more global nucleus formed, this nucleus then forms 
the transition state that then forms the native structure. The transition state for 
proteins is a high energy state cannot be characterised directly (Creighton, 1990) 
and is usually characterised indirectly only under certain conditions (Schmid, 
1992). For the model the formation of the nucleus is coupled to the formation of 
secondary and tertiary structure throughout the protein hence the name 
nucleation-condensation (Fersht, 1997). This coupling results in a highly 
cooperative folding process where there is a balancing between local structure 
formed as well as long range tertiary structure as well (Fersht, 1997). With this 
model though there is minimal accumulation of intermediates (Fersht, 1997). 
Larger proteins form separate folding units of structure that represent individual 
nucleation-condensation folding units, these units then dock to form the native 
structure (Fersht, 1997). The larger proteins therefore are more prone to form 
intermediates as the individual folding units form stable structures and the 
rearrangement and docking of these units is the rate determining step in folding 
(Fersht, 1997). 
 
Both models presented so far have not introduced the idea that a single 
polypeptide chain can take several routes to achieve the native state. One such 
model is the jigsaw-puzzle model (Harrison and Durbin, 1985). This model is 
based on the idea that protein folding, like solving a jigsaw puzzle, is a process 
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directed to an end point although the route taken to that end point can differ each. 
In the model it is also proposed that native-like native structures form during 
folding (Harrison and Durbin, 1985). This closely resembles the diffusion-
collision model proposes that small microdomains form early during folding, 
(Karplus and Weaver, 1994). The intermediates that form during folding are not 
described in terms of their structural characteristics but it is said that they are a 
heterogeneous population that is in rapid equilibrium (Harrison and Durbin, 
1985). 
 
1.1.2 Protein folding intermediates and pathways 
Protein folding models try to generalise folding mechanisms in order to create a 
“one fits all” model for all proteins. The formation of this model is based on the 
determination of protein folding pathways of several proteins. A particular 
protein’s folding pathway is only fully understood when the starting native or 
denatured state as well as intermediates formed during (un)folding can be 
positioned in the order in which they form (Creighton, 1990; Jaenicke, 1999). The 
native and unfolded state as well as stable intermediates if present at equilibrium 
can be characterized (Creighton, 1990) although the denatured state represents an 
ensemble of a number of interconverting species (Jaenicke, 1999). Kinetic 
refolding and equilibrium unfolding of -lactalbumin indicted that the equilibrium 
intermediate posses the same structure as a transient kinetic refolding 
intermediate (Ikeguchi et al., 1986). An intermediate formed early during folding 
which can be detected during equilibrium unfolding studies has been termed the 
molten globule (Seckler and Jaenicke, 1992). Kuwajima (1989) specifies the 
criteria that an early intermediate must possess in order to be termed a molten 
globule which include a high degree of native secondary structure, an overall 
compactness with buried but still mobile aromatic side chains and exposed 
hydrophobic surfaces.  
 
Intermediates are however generally unstable and poorly populated at equilibrium 
(Yon, 2001) but kinetic experiments on protein folding can detect transiently 
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formed intermediates during the folding process because the conditions can be 
manipulated in order to populate the marginally stable species and enable their 
detection (Utiyama and Baldwin, 1986). One such example of where the kinetic 
data provided more information about folding intermediates was for 
chymotrypsin inhibitor 2 (Jackson and Fersht, 1991). The presence of 
intermediates can be detected by kinetic studies but the structural details and 
nature of these species cannot be determined by these studies (Yon, 2001). The 
kinetics of folding for proteins are fitted to the sum of exponentials (Zarrine-Afsar 
and Davidson, 2004). When more than one exponential can be fitted to the data 
the presence of multiple rate limiting steps or a heterogeneous starting population 
of species is suspected (Creighton, 1990). A heterogeneous population of starting 
species often results in parallel refolding pathways as opposed to multiple kinetic 
phases with uniform staring species where the additional rate limiting steps such 
as the presence of intermediates result in sequential folding pathways. For a 
review on tests to distinguish parallel versus sequential folding pathways, see 
Wallace and Matthews (2002). Most of the work on protein folding pathways has 
been conducted for small single domain proteins and it was thought that the 
information could be transferred to larger multidomain protein by assuming that 
the domains folded as single units (Jaenicke, 1999). 
 
1.2 Domains and folding 
Domains were identified as compact substructures within proteins that are said to 
have originated from smaller nucleation sites within the protein structure that 
following rapid growth form these independent folding units (Wetlaufer, 1973). 
Many other definitions for domains also exist although they are not mutually 
exclusive and are based on interactions made within the domain and the domain 
with the rest of the polypeptide, sequence homologies, functional units, and exon 
expression to name a few (Jaenicke, 1999 and references therein). One relevant to 
the study of protein folding is where domains have been defined as having 
distinct equilibrium unfolding transitions during equilibrium unfolding (Rowe and 
Tanford, 1973).  
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The folding of multidomain proteins has been investigated for II-crystallin from 
calf eye lens and human. For these proteins it was shown that the two 
homologous domains (un)fold independently (Rudolph et al., 1990; Wenk et al., 
2000). The folding of the domains of calf eye lens protein, and not the pairing of 
these domain, is the rate-limiting step during folding (Rudolph et al., 1990). The 
pairing or docking of the two domains of II-crystallin from calf eye lens did not 
contribute at all to the kinetic mechanism of folding or the stability of the protein 
(Rudolph et al., 1990). Just as this example highlights the very independent 
folding of the domains of a protein there exists examples where that interdomain 
interactions can contribute to the folding of the domains. For type  
immunoglobulin light chain and its variable and constant fragments it was shown 
that the fragments or domains (un)fold independently although the interdomain 
interactions contributed to the refolding kinetics (Tsunenaga et al., 1987). 
Similarly interdomain contacts were said to influence to folding of the domains 
(which can fold independently) of yeast phosphoglycerate kinase (Missiakas et 
al., 1992; Osváth et al., 2005). These examples highlight that the folding of 
proteins with more than one domain is not as simple as the predicted independent 
folding of the domains with simultaneous pairing. This and the difficulty in 
correctly determining the boundaries (removing all contacts with the rest of the 
polypeptide) for domains can add great complexity to determining the folding of 
multidomain proteins (Jaenicke, 1999).  
 
A further example that points to the complex nature of the folding of multidomain 
proteins is that of gene-3-protein whose two domains (un)fold independently. The 
larger N2 domain was less stable than the N1 domain and the first transition in the 
equilibrium unfolding data corresponded to the unfolding of this domain (Martin 
and Schmid, 2003a). It must also be mentioned that although the N1 and N2 
domains unfold separately, the interdomain contacts were still stabilizing factors 
and the unlocking of the two domains is thermodynamically coupled to N2 
domain unfolding (Martin and Schmid, 2003a). The kinetics of (un)folding of 
gene-3-protein also showed that the unfolding of the two domains was connected 
(Martin and Schmid, 2003b). Prior to the docking of the domains, unfolding of 
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both domains occurred fast and independently. Following docking, however the 
unfolding was slower and more correlated (Martin and Schmid, 2003b). The 
refolding indicated that domain N1 folded faster and independently of N2, with 
domain N2 folding in a biphasic manner (Martin and Schmid, 2003b). Although 
the folding and unfolding of the N1 and N2 domains could occur independently 
the interdomain docking or coupling play an important role in the stability and 
(un)folding of this gene-3-protein (Martin and Schmid, 2003a, b). Gene-3-protein 
has independent domain folding with a very slow docking of the folded domains 
(Martin and Schmid, 2003b).  
 
The examples presented so far for the folding of multidomain proteins have 
demonstrated that the domains of multidomain proteins fold independently or at 
least as independent folding units. This however is not the case for all proteins. 
There are cases where there is a great deal of cross talk between domains and a 
high degree of cooperativity for the folding/unfolding of these proteins (Privalov 
and Potekhin, 1986). Proteins where the domains fold independently have 
optimised stability of the individual domains and then have slow pairing of these 
stable domains as a final step during folding. Other proteins may decrease the 
stability of their individual domains and use the domain interactions to stabilise 
the whole protein by more tightly linking the domains (Jaenicke, 1999). The 
kinetics of folding of the multidomain protein spectrin point to the latter 
mechanism, it was found that the domain domain interactions had profound 
effects on the folding of the proteins domains (Batey et al., 2006). The two phases 
of refolding of a two-domain spectrin unit where shown not to be due to the 
folding of the two individual domains, which was consistent with the equilibrium 
data that indicated that the folding was a cooperative all-or-nothing event (Batey 
et al., 2006). 
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1.3  Cis-trans prolyl peptide bond isomerization and protein 
folding 
Gene-3-protein was shown to have domains N1 and N2 that fold independently of 
one another but the slowest step in the folding of the protein was the domain 
docking or association, this association reaction was accelerated by mutating the 
Pro213 to a glycine residue (Martin and Schmid, 2003c). The effects of this 
mutation indicated that the biggest rate-limiting step in the folding of this protein 
was the trans to cis isomerization of the Gln212-Pro213 peptide bond (Martin and 
Schmid, 2003c). One way that parallel folding species can arise during protein 
folding is due to the presence of different cis-trans conformations about proline 
peptide bonds (Schmid, 1986a; Schmid, 1992; Wedemeyer et al., 2002). Parallel 
folding channels which has been shown to occur in the folding of Escherichia coli 
thioredoxin (Georgescu et al., 1998; Kelley and Richards, 1987), bacteriophage 
T4 thioredoxin (Borden and Richards, 1990), full length -subunit of tryptophan 
synthase (Bilsel et al., 1999), ribonuclease A (Schmid, 1986b; Houry and 
Scheraga 1996) and fragments of the α-subunit of tryptophan synthase (Zitzewitz 
and Matthews, 1999) to name a few.  
 
It was shown by kinetic studies that proteins fold along several pathways to 
achieve the native state and not just one, due to the presence of different isomers 
of prolyl peptide bonds (Schmid, 1992). Proline is unique in that the Xaa-proline 
peptide bond can exist in either the cis or the trans conformation. This is unique, 
as the cis conformation, of non-proline peptide bonds, is unstable relative to the 
trans conformation. Difference in conformation of the Xaa-proline peptide bond 
in the unfolded state is one way in which different unfolded species can arise 
(Schmid, 1986a; Wedemeyer et al., 2002). A particular Xaa-proline peptide bond 
can be in either the cis or the trans conformation in the unfolded protein although 
the trans isomer is the favoured conformation (Hinderaker and Raines, 2003). 
This was shown to be because of steric effects but also the n  	
 interaction 
between the oxygen of the peptide bond and the subsequent carbonyl carbon in 
the polypeptide (Hinderaker and Raines, 2003). In the native protein, one of the 
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isomers will be favoured or stabilized due to structural constraints that exist for 
the native protein structure formation (Schmid, 1992). Ten to thirty percent of the 
species are present in the cis isomeric form in the unfolded state of the protein 
(Brandts et al., 1975; Schmid, 1992). This means that for proteins where the cis 
isomer is present in the native protein, isomerization of the other 90-70 % of the 
species must take place during folding (Brandt et al., 1975). The identification of 
the peptide bonds that undergo isomerization during folding is important in 
assessing the role certain residues play in protein folding as well as determining 
the folding pathways of proteins (Eyles and Gierasch, 2000; Wu and Matthews, 
2002). The amino acid residue that precedes the proline residue (i.e. N-terminal 
residue to the proline) in the cis conformation affects the rate of isomerization 
(Reimer et al., 1998), the more bulky the residue the slower isomerization 
(Brandts et al., 1975). All the folding species do not require the native isomer of 
the Xaa-proline bond before folding can proceed, although the incorrect isomer 
will decrease the rate of folding (Schmid, 1986b). 
 
In the case of proline, both isomers are isoenergetic (Wedemeyer et al., 2002). 
The factors that result in kinetically distinct folding species include, a high energy 
of interconversion (20 kcal.mol-1) (Brandts et al., 1975). One other factor is that 
the unfolded protein with the non-native form of the Xaa-proline peptide bond is 
required to undergo an isomerization reaction during folding to the native state. 
The isomerization reaction (time constant of 10 to 1000 seconds at 25 ºC) is 
slower than the conformational folding of the protein (Brandts et al., 1975; 
Schmid and Baldwin 1987; Schmid, 1992; Stewart et al., 1990). It involves the 
disruption of the partial double bond character of the peptide bond (Stewart et al., 
1990; Wedemeyer et al., 2002). Prolines also play a role in folding as they 
decrease the conformational entropy of folding. When the Xaa-proline bond is in 
the cis conformation, it restricts the number of conformations that the unfolded 
polypeptide can adopt on folding to the native state. 
 
  
 
9 
1.3.1 Cis-prolines and folding nuclei 
Small regions of local structure are said to form first during folding, these regions 
or nuclei then initiate the cooperative folding process of the entire protein as it 
folds to the native state. The folding proceeds from the small structural nuclei via 
larger structured regions until the protein is fully folded. This closely resembles 
the folding as described by the diffusion-collision model (Karplus and Weaver, 
1994). Prolines are said play a role in forming the small structural folding nuclei. 
The Xaa-proline residue in the cis conformation, forms a tight bend thus 
restricting the number of conformations the polypeptide backbone can adopt as 
well as controlling local structural changes. Kelley and Richards (1987) 
demonstrated that thioredoxin cis Pro76 plays a role in forming these folding 
nuclei. Proline mutants (specifically alanine mutants) would block the formation 
of the cis conformation so destroying the folding initiation site of the local 
environment surrounding the proline (Dodge and Scheraga, 1996). A folding 
initiation site was proposed for ribonuclease A in the region of Pro93, whose 
preceding peptide bond adopts the cis isomeric form in the native state (Dodge 
and Scheraga, 1996).  
 
Proline to alanine mutants of CRABPI which has three prolines all in the trans 
conformation also indicated that even trans isomers acted as folding initiation 
sites. The P105A mutant showed no change in (un)folding, it is in a loop region 
that is flexible and therefore accommodated the new trans conformation. The 
P85A mutant displayed kinetics where the slowest phase was lost. All the Xaa-
proline bonds were in the trans conformation so the slowest phase of folding 
involved a cis to trans isomerization. The isomerization from cis to trans is the 
rate-limiting step in the folding of CRABPI and is therefore critical in folding. It 
is for this reason that Pro85 is said to be a critical folding initiation site. 
 
1.3.2 Essential and non-essential proline residues 
Prolines that form folding initiation sites would be considered essential prolines 
to critical proline residues. Xaa-proline bonds that are not in the native 
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conformation can have different effects on protein folding (Schmid and Baldwin, 
1978). Certain proline residues have no effect on folding (nonessential prolines) 
and others slow the folding of proteins (essential prolines) while others disrupt 
protein folding (critical prolines) (Wedemeyer et al., 2002). The cis-proline 
peptide bonds are said to play an important structural role in bends and turns 
(Stewart et al., 1990). The essential and critical proline residues are normally 
present in positions in the polypeptide chain that will form bends and turns in the 
native protein. Other prolines are in positions that can accommodate either the cis 
or the trans isomer at that position of the native structure (Schmid and Baldwin, 
1978). Prolines in flexible regions did not impact folding or their mutation to 
alanine or glycine whereas residues in less flexible turn regions affected 
(un)folding as was shown for staphylococcal nuclease A (Ikura et al., 1997). 
Mutants of prolines residues that are present in structurally constrained regions 
often result in destabilization of the protein and changes in the kinetics of folding. 
Pro40 for thioredoxin, located close to the active site, assumes cis conformation 
as it creates a sharp turn. A proline to alanine mutant of Pro40 resulted in a 
destabilization of mutant protein (De Lamotte-Guéry et al., 1997). If the mutation 
allows the peptide bond to maintain the conformation of the native wild-type 
protein then often no change is observed for the mutant. CRABP1 P85V mutant 
did not result in a loss of the slowest refolding phase (Burns et al., 2003) 
contradicting previous evidence that isomerization of this proline results in the 
slow refolding phase. The lack of correlation was explained due to the cis-peptide 
bond being maintained in the mutant (Burns et al., 2003). The Pro34 to serine 
mutant of thioredoxin (proline residue located in the active site sequence Cys32-
Gly33-Pro34-Cys35) had only small effects on equilibrium and kinetics data for 
oxidized protein. This was said to be because the conformation of the proline 
peptide bond is maintained due to low flexibility of the region due to the 
disulphide bond (Kelley and Richards, 1987).  
 
The evidence for essential and non-essential prolines can be found for proteins 
that possess more than one proline residue. During the folding of CRABP1 only 
the Pro105 residue was shown to have no effect on the folding kinetics of the 
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protein while Pro39 and Pro85 played roles as chain initiation sites (Eyles and 
Gierasch, 2000). The Pro39 residue of CRABP1 was shown to restrict the 
sampling of the conformational space, resulting in accelerated folding, as a 
number of non-productive folding routes are avoided (Eyles and Gierasch, 2000). 
Staphylococcal nuclease contains both an essential and a non-essential proline 
residue. Mutational studies for proline mutants of the Pro47 had little effect but 
studies on Pro117 mutant indicated that this proline is situated in an inflexible 
region, as there were changes due to the mutations (Ikura et al., 1997). Another 
protein that contains both essential and non-essential cis prolines is carbonic 
anhydrase II. Mutation of the Pro30 resulted in severely destabilised protein 
whereas mutation of the Pro202 residue had no effect on the refolding kinetics of 
the protein (Fransson et al., 1992). 
 
Essential prolines have only been identified where isomerization of the proline 
residues from trans to cis conformation occurs. An example of a protein that has 
an essential proline in the trans conformation in the naive state where 
isomerization of cis to trans isomers occurs during folding is chymotrypsin 
inhibitor 2 (Tan et al., 1997). The isomerization of Pro6 resulted in slow refolding 
species for this protein. 
 
1.3.3 Isomerisation within folding intermediates 
Peptidyl prolyl isomerization may not result in the formation of rate-limiting 
intermediates in protein folding, although the isomerization plays a central role in 
the folding of proteins (Utiyama and Baldwin, 1986). Schmid (1986b) proposed 
that the rates of isomerization during protein folding can be increased or 
decreased by the conformation of the protein. Isomerization of prolyl peptide 
bonds may take place within native structural intermediates that have formed 
during folding (Chaffotte et al., 1997; Cook et al., 1979; Kiefhaber et al., 1992b). 
During the folding of the α subunit of Trp synthase, it was shown that the 
formation of a stable intermediate provides the free energy necessary for the slow 
isomerization reaction of the Asp27-Pro28 peptide bond (Wu and Matthews, 
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2002). Borden and Richards (1990) showed that isomerization of an X-proline 
peptide bond occurs in a compact structural form during the folding of phage T4 
thioredoxin. In the folding of antibody scFv fragment, it was shown by H/D 
experiments and ESI-MS that the folding of the core of one of the domains 
occurred prior to isomerization (Jäger and Plückthun, 2000). The domains of the 
antibody scFv fragment fold prior to isomerization but the isomerization results in 
the correct interface formation, indicating that a proline residue can be essential 
but does not prevent structural folding. 
 
The formation of structure can either accelerate isomerization (Schmid, 1986b) or 
slow the isomerization down a great deal (Kiefhaber and Schmid, 1992). With the 
proline to alanine mutants of CRABPI, which has three prolines all in the trans, 
the folding of P39A is slowed compared to the wild-type. For this reason, it was 
stated that the isomerization forms an early structure that then restricts certain 
folding conformations (more specifically is a helix termination signal) resulting in 
faster folding than that shown by the mutant (Eyles and Gierasch, 2000).  
 
1.4 Peptidyl prolyl cis-trans isomerases 
It is not surprising that due to the rate limiting significance of cis-trans 
isomerization during folding that enzymes known as peptidyl prolyl cis-trans 
isomerases (EC 5.2.1.8) exists that catalyse the slow isomerization steps in 
protein folding (Göthel and Marahiel, 1999; Schiene and Fischer, 2000). This 
catalysis is necessary to prevent aggregation and proteolysis and allows functional 
protein to be produced (Walsh et al., 1992). The PPIs therefore have important 
roles to play in the folding and trafficking of proteins (Walsh et al., 1992). There 
are three families of PPIs (Göthel and Marahiel, 1999). The families are the 
cyclophilins, FKBP’s and parvulins (Göthel and Marahiel, 1999; Schiene and 
Fischer, 2000). The cyclophilins bind cyclosporine A, the FKBP’s bind FK506 
and rapamycin, while the parvulins bind and are inactivated by juglone, a 5-
hydroxy-1,4-naphthoquinone (Göthel and Marahiel, 1999). 
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Trigger factor is homologous to the FKBP proteins with three domains and a 
molecular mass of 48 kDa (Zarnt et al., 1997) although Escherichia coli trigger 
factor shows no affinity for FK506 (Göthel and Marahiel, 1999). Trigger factor is 
not found in eukaryotes (Göthel  and Marahiel, 1999) and is associated with the 
large ribosomal subunit of prokaryotic ribosomes and binds newly synthesized 
polypeptide chains until they are released from the ribosome (Hartl and Hartl, 
2002; Schiene and Fischer, 2000). The binding of trigger factor to the polypeptide 
chains is based on the recognition of stretches of hydrophobic amino acids rather 
than proline residues (Hartl and Hartl, 2002). As well as having PPI activity, 
trigger factor also has the ability to hold newly synthesized polypeptides in a 
competent state for folding until they are released from the ribosome (Hartl and 
Hartl, 2002). Trigger factor therefore does not only act as a PPI but also plays a 
role as a chaperone in catalyzing protein folding (Liu and Zhou, 2003).    
 
Members of the FKBP family of PPIs are found in all organisms, range in size 
form 12 kDa to 52 kDa and are inhibited by makrolides FK506 and rapamycin 
(Göthel and Marahiel, 1999). FKBP proteins are found in the cytoplasm, localized 
in the endoplasmic reticulum as well as membrane-localized (Walsh et al., 1992; 
Göthel and Marahiel, 1999). These PPIs have been found to be localized to the 
large subunit of prokaryotic ribosomes (Schiene and Fischer, 2000). FKBP-12 is 
an abundant, cytosolic, protein composed of a 108 amino acid residues (Göthel 
and Marahiel, 1999). The amino acid sequence is highly conserved between 
human FKBP-12 and rat FKBP-12 and between human FKBP-12 and rabbit 
FKBP-12 (Göthel and Marahiel, 1999). FKBP-12 protein is a peptidyl prolyl 
isomerase that is said to play an integral role in channel gating for the intracellular 
calcium release channel complex (Göthel and Marahiel, 1999).  
 
The importance of these catalytic enzymes within the cell is to produce fully 
functional proteins molecules. Their use however in elucidating folding pathways 
is to accelerate the rate of cis-trans isomerization folding events. Peptidyl- prolyl 
cis-trans isomerase purified from pig kidney was shown to catalyze the slow steps 
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of refolding for a number of proteins (Lang et al., 1987). These slow steps had 
previously been identified as involving a cis-trans isomerization. By catalyzing 
only the steps involving isomerization they can be used to identify the 
isomerization step during folding.  
 
1.5 Conserved cis-proline in the thioredoxin-like 
superfamily 
The thioredoxin superfamily comprises 15 protein families. These 15 families 
include: the thioltransferases, protein disulphide isomerases, calsequestrin, 
disulphide-bond formation facilitator DsbA, N-terminal domain (domain 1) of 
glutathione S-transferases (GSTs), phosducin, domain 1 of endoplasmic reticulum 
protein ERP29, splicesomal protein U5-15kD,  SH3-binding, glutamic acid-rich 
protein-like, Circadian oscillation regulator KaiB, C-terminal domain or domain 2 
of disulphide-bond isomerase DsbC/DsbG, glutathione peroxidases, thioredoxin-
like 2Fe-2S ferredoxin, arsenate reductase ArsC and thioredoxin containing 
proteins Txn15 (http://scop.mrc-lmb.cam.ac.uk/scop/data/scop.b.d.fh.b.html, 
Murzin et al., 1995). The thioltransferase family of proteins includes thioredoxin 
and small glutaredoxin proteins (http://scop.mrc-
lmb.cam.ac.uk/scop/data/scop.b.d.fh.b.html, Murzin et al., 1995). Within the GST 
family, there are 16 classes. These classes include the GSTs of which there are 11 
classes: the Pi, Mu, Alpha, Theta, Sigma, Omega, Zeta, Delta, Tau, Phi and Beta. 
Then the five other classes that are found with in the GST family include 
Plasmodium falciparum GST, the yeast prion protein (yeast prion protein 2), 
Grx2, GST-like domain of elongation factor 1-Gamma, and chloride intracellular 
channel 1 (Clic1) (http://scop.mrc-lmb.cam.ac.uk/scop/data/scop.b.d.fh.b.f.html, 
Murzin et al., 1995).  
 
A structure based sequence alignment of members of the GST family of proteins 
shows the conserved proline residue (Figure 2). This is in agreement with a 
published alignment that indicate that there is a conserved cis-proline at the 
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                   10        20        30        40        50        60 
           ....*....|....*....|....*....|....*....|....*....|....*....| 
1G7O_A   1 ~~~~~~~~~~~~~~~~~~~~~~~MKLYIY~~~~~~~~DHCPYCLKARMIFGLKNIPVELH 29 
1K0M_A   1 ~~~~~~~~~~~~~~~~maeeqpqVELFVKagsdgakiGNCPFSQRLFMVLWLKGVTFNVT 44 
1GUH_A   1 ~~~~~~~~~~~~~~~~~~~~aekPKLHYF~~~~~~~~NARGRMESTRWLLAAAGVEFEEK 32 
1EEM_A   1 msgesarslgkgsappgpvpegsIRIYSM~~~~~~~~RFCPFAERTRLVLKAKGIRHEVI 52 
1FW1_A   1 ~~~~~~~~~~~~~~~~~~mqagkPILYSY~~~~~~~~FRSSCSWRVRIALALKGIDYKTV 34 
1GNW_A   1 ~~~~~~~~~~~~~~~~~~~~~agIKVFGH~~~~~~~~PASIATRRVLIALHEKNLDFELV 31 
1GSQ     1 ~~~~~~~~~~~~~~~~~~~~~pkYTLHYF~~~~~~~~PLMGRAELCRFVLAAHGEEFTDR 31 
1GSS_A   1 ~~~~~~~~~~~~~~~~~~~~~ppYTVVYF~~~~~~~~PVRGRCAALRMLLADQGQSWKEE 31 
1GWC_A   1 ~~~~~~~~~~~~~~~~~maggddLKLLGA~~~~~~~~WPSPFVTRVKLALALKGLSYEDV 35 
1HQO_A   1 ~~~~~~veysritkffqeqplegYTLFSH~~~~~~~~RSAPNGFKVAIVLSELGFHYNTI 46 
1JLV_A   1 ~~~~~~~~~~~~~~~~~~~~~~~MDFYYL~~~~~~~~PGSAPCRAVQMTAAAVGVELNLK 29 
1N2A_A   1 ~~~~~~~~~~~~~~~~~~~~~~~MKLFYKp~~~~~~~GACSLASHITLRESGKDFTLVSV 30 
1NHY_A   1 ~~~~~~~~~~~~~~~~~~~~xsqGTLYANf~~~~~~~RIRTWVPRGLVKALKLDVKVVTP 33 
1PA3_A   1 ~~~~~~~~~~~~~~~~~~~mgdnIVLYYF~~~~~~~~DARGKAELIRLIFAYLGIEYTDK 33 
2LJR_A   1 ~~~~~~~~~~~~~~~~~~~~~mgLELFLD~~~~~~~~LVSQPSRAVYIFAKKNGIPLELR 31 
6GST_A   1 ~~~~~~~~~~~~~~~~~~~~~~pMILGYW~~~~~~~~NVRGLTHPIRLLLEYTDSSYEEK 30 
                    70        80        90       100       110       120 
           ....*....|....*....|....*....|....*....|....*....|....*....| 
1G7O_A  30 VLLNDDAEtpt~~~~~~~~~~RMVGQKQVPILQKDDs~~RYMPESMDIVHYVDKLDGK~~ 75 
1K0M_A  45 TVDTKRRTetvq~~~~~~~~~KLCPGGELPFLLYGT~~~EVHTDTNKIEEFLEAVLCPpr 92 
1GUH_A  33 FIKSAEDLdklrnd~~~~~~~GYLMFQQVPMVEIDG~~~MKLVQTRAILNYIASKYNL~~ 80 
1EEM_A  53 NINLKNKPewff~~~~~~~~~KKNPFGLVPVLENSQg~~QLIYESAITCEYLDEAYPGkk 101 
1FW1_A  35 PINLIKDGgqqfskdfq~~~~ALNPMKQVPTLKIDG~~~ITIHQSLAIIEYLEETRPTpr 87 
1GNW_A  32 HVELKDGEhkkepfl~~~~~~SRNPFGQVPAFEDGD~~~LKLFESRAITQYIAHRYENqg 82 
1GSQ    32 VVEMADWPnlk~~~~~~~~~~ATMYSNAMPVLDIDG~~~TKMSQSMCIARHLAREFGL~~ 76 
1GSS_A  32 VVTVETWQegslk~~~~~~~~ASCLYGQLPKFQDGD~~~LTLYQSNTILRHLGRTLGL~~ 78 
1GWC_A  36 EEDLYKKSelllk~~~~~~~~SNPVHKKIPVLIHNG~~~APVCESMIILQYIDEVFAStg 84 
1HQO_A  47 FLDFNLGEhrapefv~~~~~~SVNPNARVPALIDHGxdnLSIWESGAILLHLVNKYYKet 100 
1JLV_A  30 LTNLMAGEhmkpefl~~~~~~KINPQHCIPTLVDNG~~~FALWESRAICTYLAEKYGKdd 80 
1N2A_A  31 DLMKKRLEngddyf~~~~~~~AVNPKGQVPALLLDDg~~TLLTEGVAIMQYLADSVPDrq 81 
1NHY_A  34 DAAAEQFA~~~~~~~~~~~~~RDFPLKKVPAFVGPKg~~YKLTEAXAINYYLVKLSQDdk 78 
1PA3_A  34 RFGVNGDAfvefknfkke~~~KDTPFEQVPILQIGD~~~LILAQSQAIVRYLSKKYNI~~ 85 
2LJR_A  32 TVDLVKGQhkskefl~~~~~~QINSLGKLPTLKDGD~~~FILTESSAILIYLSCKYQTpd 82 
6GST_A  31 RYAMGDAPdydrsqwlnekfkLGLDFPNLPYLIDGS~~~RKITQSNAIMRYLARKHHL~~ 85 
                   130       140       150       160       170       180 
           ....*....|....*....|....*....|....*....|....*....|....*....| 
1G7O_A  76 ~~~~~~~~~PLLTGKRSPAIEEWLRKVNGYANklllprfaksafdefstpaarkyfvdkk 126 
1K0M_A  93 ~~~~~~~~~YPKLAALNPESNTAGLDIFAKFSayiknsnpaln~~~~~~~~~~~~~~~~~ 126 
1GUH_A  81 ~~~~~~~~~YGKDIKERALIDMYIEGIADLGEmilllpvcppeekd~~~~~~~~~~~~~~ 117 
1EEM_A 102 l~~~~~~~~LPDDPYEKACQKMILELFSKVPSlvgsfirsqnk~~~~~~~~~~~~~~~~~ 136 
1FW1_A  88 l~~~~~~~~LPQDPKKRASVRMISDLIAGGIQplqnlsvlkqvge~~~~~~~~~~~~~~~ 124 
1GNW_A  83 tnllqtds~KNISQYAIMAIGMQVEDHQFDPVasklafeqifksiyglttde~~~~~~~~ 133 
1GSQ    77 ~~~~~~~~~DGKTSLEKYRVDEITETLQDIFNdvvkikfapeaakeavq~~~~~~~~~~~ 116 
1GSS_A  79 ~~~~~~~~~YGKDQQEAALVDMVNDGVEDLRCkyisliytnye~~~~~~~~~~~~~~~~~ 112 
1GWC_A  85 psl~~~~~~LPADPYERAIARFWVAYVDDKLVapwrqwlrgkte~~~~~~~~~~~~~~~~ 122 
1HQO_A 101 gnpllwsddLADQSQINAWLFFQTSGHAPXIGqalhfryfhsqkia~~~~~~~~~~~~~~ 146 
1JLV_A  81 kl~~~~~~~YPKDPQKRAVVNQRLYFDMGTLYqrfadyyypqifakq~~~~~~~~~~~~~ 120 
1N2A_A  82 ll~~~~~~~APVNSISRYKTIEWLNYIATELHkgftplfrpdtpe~~~~~~~~~~~~~~~ 119 
1NHY_A  79 xktqllg~~ADDDLNAQAQIIRWQSLANSDLCiqiantivplkggapynk~~~~~~~~~~ 126 
1PA3_A  86 ~~~~~~~~~CGESELNEFYADMIFCGVQDIHYkfnntnlfk~~~~~~~~~~~~~~~~~~~ 117 
2LJR_A  83 hw~~~~~~~YPSDLQARARVHEYLGWHADCIRgtfgiplwvqvlgpligvqvpe~~~~~~ 129 
6GST_A  86 ~~~~~~~~~CGETEEERIRADIVENQVMDNRMqlimlcynpdfe~~~~~~~~~~~~~~~~ 120 
                             
Figure 1: Structure based sequence alignment.  
Alignment was conducted with sequences of GST family members (A chain 
unless otherwise stated), was done using Cn3D 4.1 (Wang et al., 2000). The 
resulting alignment shows clearly the secondary structural elements of each 
protein, helices are in green, -strands in orange and other structures in blue. 
Amino acid sequences were obtained from the NCBI 
(http://www.ncbi.nlm.nih.gov) the Molecular Modeling Database (MMDB)( 
Marchler-Bauer et al., 2005) using the PDB accession codes (Table 1) obtained 
from SCOP (http://scop.mrc-lmb.cam.ac.uk/scop/data/scop.b.d.fh.b.html, Murzin 
et al., 1995). The conserved proline residues are in red.  
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Table 1: Proteins used for the sequence alignment  
The class of GST to which the proteins selected for the structure-based 
sequence alignment (Figure 1) are listed below as well as the reference for 
each of the structures. A protein from each one of the 16 classes of GST was 
selected for the alignment, from SCOP (http://scop.mrc-
lmb.cam.ac.uk/scop/data/scop.b.d.fh.b.html, Murzin et al., 1995). 
 
 
PDB code GST class Reference for structure 
1G7O Grx2 Xia et al., 2001 
1K0M chloride intracellular channel 1 (Clic1) Harrop et al., 2001 
1GUH Alpha Sinnig et al., 1993 
1EEM Omega Board et al., 2000 
1FW1 Zeta Polekhina et al., 2001 
1GNW Phi Reinemer et al., 1996 
1GSQ Sigma Ji et al., 1994 
1GSS Pi Reinemer et al., 1992 
1GWC Tau Thom et al., 2002 
1HQO yeast prion protein ure2p (nitrogen 
regulation fragment) 
Umland et al., 2001 
1JLV Delta Oakley et al., 2001 
1N2A Beta Rife et al., 2003 
1NHY GST-like domain of elongation factor 
1-gamma  
Jeppesen et al., 2003 
1PA3 Plasmodium falciparum GST Perbandt et al., 2004 
2LJR Theta Rossjohn et al., 1998 
6GST Mu Ji et al., 1994 
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N-terminus of β-strand 3, for most of the members of the thioredoxin superfamily 
(Nathaniel et al., 2003). Spliceosomal protein U5-15kD and seven of the 10 
members of the glutathione peroxidase-like family did not have the conserved cis-
proline (Nathaniel et al., 2003). The conserved cis-Proline loop falls between 2 
and 3 secondary structural elements of the thioredoxin fold (Martin, 1995). GST 
A1-1 conserved cis bond is between Val54-Pro55 (Sinning et al., 1993). Clic1 
2,3,4,5, Omega, Pi and Beta GSTs all have the conserved cis-proline residue 
(Cromer et al., 2002). The conserved cis-proline is required for the members of 
the thioredoxin superfamily that have short sequences connecting these two 
structural elements, and thus requiring the sharp bend the cis-proline residue 
offers (Nathaniel et al., 2003). Cis-proline peptide bonds are found primarily in 
bends and turns in protein structures, indicating this is their specific structural role 
(Stewart et al., 1990). Structural comparisons of the glutathione transferases 
indicate that, where the loop that connects the -helix 2 and the -strand 3 of the 
thioredoxin fold, there is a highly conserved cis-proline residue (Dirr et al., 1994; 
Sheehan et al., 2001). This cis-proline loop plays an important role in maintaining 
the protein’s catalytically active structure (Allocati et al., 1999; Sheehan et al., 
2001).  
 
Grx2 shows low sequence identity to any other proteins as was shown by CE 
(Shindyalov and Bourne, 1998). The results of a search for structural neighbours 
Grx2 indicated that the highest sequence identity is 22.9 % (for a T4 
bacteriophage glutaredoxin). Grx2 does however show structural similarity to 
glutathione S-transferases (GSTs) (Xia et al., 2001) and is said to represent the 
ancestral precursor of the conical GSTs (Ladner et al., 2004). Cytosolic GSTs are 
dimeric enzymes, with each subunit possessing two domains (Dirr et al., 1994). 
The structural similarity of Grx2 and GSTs is between a single subunit of GST 
and the monomeric Grx2. The domain 1 of Grx2 and cytosolic GSTs both have a 
four stranded mixed β-sheet and three α-helices (Dirr et al., 1994; Sinnig et al., 
1993; Xia et al., 2001). The domain 2 of Grx2 is composed of α-helices and 2 
short 310 helices joined by loops (Xia et al., 2001), and GSTs are mainly α-helical 
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with the helices joined by short connections (Sinnig et al., 1993). The overall fold 
of human Theta GST and Omega GST is very similar to that of Grx2 although 
parts of the structure are derived from different parts of the sequence (Xia et al., 
2001). Theta GST is said to be an ancestral precursor to the dimeric GSTs 
(Pemble et al., 1996) 
 
1.6 Glutaredoxin 2 
Glutaredoxin (Grx) was discovered as a component of a hydrogen donor system 
for Escherichia coli, which did not involve thioredoxin (Holmgren, 1976). Grx is 
reduced by glutathione (GSH), which in turn is reduced by NADPH and 
glutathione reductase. Reduced glutaredoxin is then involved in the reduction of 
ribonucleotide-diphosphate reductase (RR) (Holmgren, 1976) (Figure 2). Later it 
was shown that Escherichia coli has 3 glutaredoxins, namely Grx1, Grx2 and 
Grx3 (Aslund et al., 1994). 
 
Grx2 a cytosolic glutaredoxin with a molecular mass of 25 kDa, (Vlamis-
Gardikas et al., 1997) but does not show activity as a hydrogen donor for 
ribonucleotide reductase which is atypical for glutaredoxins (Aslund et al., 1994). 
Grx2 contains the active site sequence Cys-Pro-Tyr-Cys (Vlamis-Gardikas et al., 
1997) similar to other glutaredoxins and identical to Grx1 and Grx3 of 
Escherichia coli (Holmgren and Aslund, 1995). Grx2 has a high redox potential 
and oxidoreductase activity (Vlamis-Gardikas et al., 1997) and catalyses the 
general GSH-disulphide oxidoreductase assay with -hydroxyethyl, a small 
disulphide, as a substrate (Holmgren and Aslund, 1995; Vlamis-Gardikas et al., 
1997). Grx2 also catalyses the reduction of arsenate by ArsC to arsenite, a 
product that is extruded from the cell (Shi et al., 1999). The reduction of PAPS 
reductase (Vlamis-Gardikas et al., 2002) and the cleavage and formation of 
glutathione protein mixed disulfide bonds (Lundstrom-Ljung et al., 1999) are 
carried out by all three glutaredoxins. Grx2 is a better catalyst than Grx1 and  
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                                    NADPHred                  Glutathionered                 Glutaredoxinred                RRred   
                                            Glutathione    reductase 
 
                                     NADPoxid                Glutathioneoxid                Glutaredoxinoxid              RRoxid 
 
 
 
 
 
 
Figure 2: Schematic representation of the reduction of ribonucleotide-diphosphate reductase by glutaredoxin.  
red refers to the reduced state, oxid refers to the oxidized state, and RR is ribonucleotide-diphosphate reductase.  
 
  
 
20 
Grx3 and protein disulfide isomerase for the reduction of glutathionylated 
ribonuclease A (Lundstrom-Ljung et al., 1999).  
 
The Grx2 protein structure (Xia et al., 2001) resembles a two domain monomeric 
protein (Figure 3). For Grx2 to have its oxidoreductase activity, both domain 1 
and domain 2 of this monomeric protein are required (Vlamis-Gardikas et al., 
1997). Domain 1 contains residues 1 to 72 and has the typical glutaredoxin-
thioredoxin fold (Xia et al., 2001). In Grx2 this fold is composed a four strand 
mixed β-sheet (β1, β2, β3 and β4) and this mixed β-sheet is then flanked by three 
α-helices (α1, α3 and α2). Domain 1 is joined to domain 2 by an 11 residue 
linker. Domain 2 contains residues 83 to 215 and consists of six α-helices and 2 
short 310 helices, these are all connected by loops. Contacts between the domains 
are mainly hydrophobic with some hydrogen bonds (Xia et al., 2001).  
 
Grx2 has 12 proline residues, 11 of which are in the trans conformation. The 
peptide bond that is in the cis conformation is the Val48-Pro49 bond and this 
bond is located immediately before the third β strand (Xia et al., 2001) (Figure 3). 
This proline residue which is located before the third β strand is located in this 
same position and is in the same conformation in all 3 glutaredoxins (Xia et al., 
2001) it represents the conserved cis-proline found in the thioredoxin family (see 
section 1.5 and Figure 1). There are two tryptophan residues in Grx2, Trp89 and 
Trp190 both are located in the domain 2 and two cysteine residues (Cys9 and 
Cys12), which are structurally close to the cis-proline (Figure 3).  
  
1.7 The thioredoxin family folding and isomerization 
A highly cooperative equilibrium unfolding transition was obtained with 
guanidine hydrochloride as denaturant and a single unfolding kinetic phase 
(Kelley and Stellwagen, 1984). The refolding kinetics however dispute this 
cooperative two-state process with three refolding phases occurring, the slowest  
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Figure 3: Structure of wild-type glutaredoxin 2  
Structure was obtained from the protein data bank (1g70) and viewed with Swiss 
PDB viewer (ver 3.7) (Guex and Peitsch, 1997), showing the two domains, 
domain 1 (green) and the domain 2 (blue). The Pro49 residue, which is in the cis 
conformation, is represented in pink. The cysteine residues are yellow and the 
tryptophan residues are red in colour.  
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of which involves an isomerization (time constant of 300 to 800 sec) (Kelley and 
Richards, 1987; Kelley and Stellwagen, 1984). Kelly and Richards (1987) 
identified an intermediate for the folding of this protein and conducted mutational 
studies for thioredoxin. An alanine and a serine were substituted at Pro76 these 
mutants are destabilized and the slowest phase of refolding is abolished. The 
Ile75-Pro76 peptide bond is in the only one of the five X-proline peptide bonds in 
the cis conformation in the native wild-type protein (Eklund et al., 1984). The 
results indicate the Pro76 plays an important role in the folding of this protein 
although is not required to be in the cis conformation for the association of the 
two subdomains of thioredoxin (Chaffotte et al., 1997). Georgescu et al. (1998) 
identified more than the three refolding phases for Escherichia coli thioredoxin, a 
burst phase and four observable refolding phases (very rapid, rapid, medium, and 
slow phases). The burst phase species were heterogeneous and the slow phase was 
confirmed to be the isomerization phase for the Ile75-Pro76 peptide bond. A 
parallel folding pathway is proposed for the folding of thioredoxin, where the 
isomerization plays a role in forming the heterogeneous unfolded population 
(Georgescu et al., 1998). The folding of thioredoxin was further dissected and it 
was found that a folding nucleation site exists, this site corresponds to the 2 and 
4 strands that zip together forming a -sheet (Tasayco et al., 2000). It has been 
discussed how X-proline peptide bonds can undergo isomerization in compact 
folded intermediates (see section 1.3.3), which is said to be the case for 
thioredoxin (Chaffotte et al., 1997). Kelley et al. (1986) had also identified two 
refolding intermediates during the folding of thioredoxin that are said to form 
prior to isomerization. 
 
Disulphide-bond isomerase A (DsbA), a member of the thioredoxin-like 
superfamily, has a conserved cis-proline. This Pro151 residue is involved in the 
stability and catalytic function of DsbA (Charbonnier et al., 1999). The evidence 
for the involvement of this residue was obtained by creating a mutant (proline to 
alanine) which showed a decreased stability and low activity when compared to 
the wild-type protein (Charbonnier et al., 1999).  
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1.7.1 Glutathione transferase family members and folding 
The equilibrium unfolding of yeast prion protein 2 displayed single sigmoidal 
transitions, which were protein concentration independent indicting that unfolding 
and dimer dissociation is not linked (Perret et al., 1999). An additional protein 
concentration dependent transition was later observed for the unfolding of this 
protein indicating that dimer dissociation occurs later during unfolding (Thual et 
al., 2001). The unfolding of this protein was therefore said to involve the 
unfolding of the protein prior to dissociation of the dimer to form monomeric 
forms. A stable unfolding intermediate was also identified although the pathway 
for (un)folding could not be determined from these equilibrium data (Thual et al., 
2001). The intermediate detected by equilibrium unfolding was later identified 
during kinetic unfolding studies and multiple kinetic phases observed during the 
refolding of the protein (Galani et al., 2002). These multiple refolding phases are 
not only due to the presence of different cis-trans proline isomers this protein that 
contains 12 proline residues one of which is in the cis conformation in the native 
state but also due to the formation of dimeric intermediates of yeast prion protein 
2, which were not limited by proline isomerization (Galani et al., 2002). During 
the folding of yeast prion protein 2, there is competition between folding via an 
on-pathway dimeric intermediate and off-pathway aggregation (Galani et al., 
2002). The aggregation pathway is facilitated by the formation of a monomeric 
aggregation prone species (Galani et al., 2002). Isomerization does however occur 
late in refolding following the formation of a dimeric on-pathway intermediate.  
 
The unfolding of human GST A1-1 was well described by a sequential unfolding 
pathway where the domains of the subunits dissociate followed by complete 
unfolding of the domains and subunits (Wallace et al., 1998). The biphasic 
kinetics of unfolding was not expected for the two-state equilibrium unfolding 
transition (Wallace et al., 1998). The refolding of human GST A1-1 also does not 
involve a simple two-state transition from unfolded monomer to folded dimer 
(Wallace and Dirr, 1999). During the early stages of folding, structural monomers 
are formed which have native secondary structure and exposed hydrophobic 
surfaces (Wallace and Dirr, 1999). Dimerization then occurs by parallel 
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intermediate and fast folding events. A trans-to-cis isomerization event occurs 
that limits the rate of dimerization (Wallace and Dirr, 1999). This isomerization 
event is associated with the intermediate phase (also an association reaction 
during this phase) during folding and is said to result in the parallel refolding fast 
and intermediate phases (Wallace and Dirr, 1999). Once dimerization has taken 
place, a slow folding phase takes place. It is during this phase that the GST A1-1 
undergoes the final reorganization to form functional protein (Wallace and Dirr, 
1999).  
 
A P56G mutant of GST A1-1 indicated that the cis-proline is involved in 
maintaining the conformational stability as well as catalytic function of the 
protein (Nathaniel et al., 2003). A different scenario arose for glutathione 
transferase B1-1 from Proteus mirabilis. A P53S mutant had refolding and 
unfolding kinetics, which were indistinguishable from the wild-type protein and 
there was no evidence that the mutant destabilized the protein. The mutant did 
however result in lower antibiotic binding and showed small local structural 
changes in region of the Ser53 (Allocati et al., 1999). 
 
1.8  Objectives 
The principle out come of this study is an unfolding/refolding pathway s for the 
monomeric, GST homologue Grx2. The unfolding/refolding pathway for the 
thioredoxin, yeast prion protein 2 and GST A1-1 indicate that the folding of these 
related proteins does not simply involve single transition from unfolded to native 
protein (see section 1.7). Wild-type Grx2, AEDANS labelled Grx2 and a mutant, 
Y58W Grx2 were used in order to study the (un)folding of Grx2. Single-jump and 
double-jump kinetic studies also shed light on the unfolding/refolding pathway. 
The involvement of a possible isomerization of the Val48-Pro49 cis peptide bond 
was also assessed in the folding of the protein. For many of the structurally 
related proteins an isomerization of the conserved cis-proline as well as the 
presence of refolding intermediates influenced the folding of these proteins. 
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Identification of potential kinetic intermediates and the positioning of these 
intermediates in terms of folding reactions such as isomerization were conducted. 
Grx2 is composed of two domains that could affect the (un)folding of this protein. 
The exact effect in terms of the unfolding and refolding was to be assessed. One 
further question that was answered about these domains is whether they could 
result in separate folding pathways. If these domains do result in separate folding 
pathways, would a parallel or sequential folding pathway result? 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
26 
2 EXPERIMENTAL PROCEDURES  
2.1 Materials 
Ultrapure (99.5 %) urea was purchased from BDH laboratory supplies (Poole 
Dorset, U.K.) and ultrapure guanidine hydrochloride was purchased from Roche 
Diagnostics (Mannheim, Germany). DEAE-Sepharose, IAEDANS, L-ascorbic 
acid, and DCIP were purchased from Sigma (St. Louis, MO USA). DTNB was 
purchased from Boehringer Mannheim (Ingelheim, Germany). DTT was 
purchased from Whitehead Scientific (Cape Town, South Africa) or Inqaba 
Biotech (Pretoria, South Africa). All other reagents were of analytical grade. The 
pET24a plasmid encoding the cDNA sequence for Grx2 was a generous gift from 
Dr. J. Dyson (The Scripps Institute, California, USA) (Xia et al., 1999). Purified 
hFKBP-12 was a generous gift from Dr. Jens-U Rahfeld (EMBL, Heidelberg 
Germany). Inqaba Biotech (Pretoria, South Africa) conducted all sequencing to 
confirm the identity of the plasmids.  
 
2.2 Mutagenesis to generate the Y58W variant of Grx2   
The Y58W mutant was introduced into the Grx2 coding region of the pET24a 
plasmid using the QuikChange™ Site-directed Mutagenesis kit (Papworth et al., 
1996) from Stratagene (La Jolla, USA). Oligonucleotide primers for the 
mutagenesis, were designed in accordance with the mutagenesis kit instructions, 
using the web based program Primer X (http://bioinformatics.org/primerx/) as 
well as Gene Runner computer software package v3.05. Inqaba Biotech (Pretoria, 
South Africa) synthesized the primers:  
Y58W forward: 5' G CAA AAA GAT GAC AGC CGC TGG ATG CCA GAA AGC 3'  
Y58W reverse: 5' GCT TTC TGG CAT CCA GCG GCT GTC ATC TTT TTG C 3'.  
 
The nucleotides in bold print are the codon for a tryptophan (TGG), originally 
tyrosine (TAT). The mutagenesis reaction that includes, thermocycling and post 
  
 
27 
thermocycling DNA digestion, was carried out as specified by the QuikChange™ 
Site-directed Mutagenesis kit from Stratagene (La Jolla, USA) (Papworth et al., 
1996). The amount of double stranded template DNA used for the mutagenesis 
reaction was 20 ng and the extension time was 6 minutes at 68 ºC. Digestion of 
the parental DNA by the restriction enzyme DpnI, digestion was continued for a 
further 1 hour at 20 ºC following the specified hour long digestion at 37 °C. 
Plasmid encoding Y58W Grx2 was then used to transform XL1-Blue 
supercompetent Escherichia coli cells as stated in the mutagenesis kit manual. 
Transformed cells were grown on kanamycin containing plates from which a 
colony was selected. Plasmid DNA was extracted from a culture of cells grown 
from the selected colony, using the Flexiprep ™ Kit form Amersham Biosciences 
(Buckinghamshire, U.K.). The incorporation of the desired mutation in the 
pET24a plasmid DNA was confirmed by sequencing of the plasmid DNA, using 
the T7 terminator primer. The Y58W mutant plasmid DNA was then transformed 
into Escherichia coli BL21(DE3) cells to produce an expression system for the 
mutant protein. 
 
2.3 Wild-type and Y58W Grx2 expression and purification 
The recombinant expression system for wild-type and Y58W Grx2 is composed 
of the pET24a plasmid with the wild-type Grx2 gene insert or the Y58W gene 
insert in Escherichia coli strain BL21(DE3)pLysS cells or BL21(DE3) cells, 
respectively. Based on the expression system 30 µg/ml kanamycin was added to 
the growth media for both proteins and for wild-type Grx2 only, an additional 30 
µg/ml chloramphenicol was added. The initial purification protocol used to obtain 
wild-type Grx2 involved diluting an overnight culture 50 times into 1 litre Luria-
Bertani media followed by overexpression of Grx2. Overexpression was induced 
by addition of IPTG to cell culture (with an optical density of 0.6) to a final 
concentration of 1mM. Following induction the cells were grown for a further 15 
hours and then harvested by centrifugation at 5000 rpm before being resuspended 
in 20 mM Tris-HCl buffer, pH 10, containing 2 mM magnesium chloride, 1 mM 
EDTA, 0.02 mg/ml DNase I and 0.02 % sodium azide. The resuspended cells 
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were then lysed by sonication and the lysate centrifuged at 13 000 rpm for 20 
minutes. The protein was then purified using anion exchange chromatography as 
described previously (Aslund et al., 1994; Vlamis-Gardikas et al., 1997; Xia et 
al., 2001). Bound protein was then eluted from the DEAE-Sepharose column with 
50 mM Tris-HCl buffer, pH 8, containing 0.02 % sodium azide. Contaminating 
proteins that eluted along with wild-type Grx2 from the DEAE-Sepharose column 
were then removed by filtration chromatography on a G-75 Sephadex column. 
The column was pre-equilibrated with 50 mM sodium phosphate buffer, pH 7, 
containing 50 mM sodium chloride, 1 mM DTT and 0.02 % sodium azide. This 
purification protocol did not result in pure wild-type Grx2 and gave a low yield of 
14 mg protein per litre of Luria-Bertani media, therefore it had to be optimised. 
Changes for the optimised protocol, which was used for the purification of wild-
type and Y58W Grx2 included replacing the Luria-Bertani media with 2XYT rich 
media. Anion exchange chromatography was conducted using an AKTA prime 
system with a chart recorder (Amersham Biosciences, Vienna Austria), with this 
system bound wild-type Grx2 or Y58W Grx2 were eluted from the DEAE-
Separose column using a pH gradient from pH 9 to pH 8. The gradient was 
produced by mixing 20 mM Tris-HCl, pH 9, 0.02 % sodium azide with 50 mM 
Tris-HCl, pH 8, 0.02 % sodium azide. No further filtration chromatography was 
conducted. The purified wild-type Grx2 was then dialysed and snap frozen at -70 
ºC; frozen protein would then be thawed on ice and dialysed before use. Purified 
Y58W Grx2 once purified was dialysed and used within a week. The dialysis 
buffer for both proteins was a 50 mM sodium phosphate buffer, pH 7, containing 
50 mM sodium chloride, 1 mM DTT and 0.02 % sodium azide. Dialysis was 
conducted at 4 ºC with three changes of dialysis buffer, each change lasting for 4 
hours. Unless otherwise stated all experiments for wild-type and Y58W Grx2 
were conducted in the dialysis buffer.  
 
2.4 SDS-PAGE 
During the purification protocols for wild-type Grx2 and Y58W Grx2 as well as 
for the size determination of the denatured, reduced, purified proteins, SDS-
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PAGE with a discontinuous buffer system of Laemmli (1970) was used to assess 
the size and homogeneity of the purified proteins. SDS-PAGE gels with a 15 % 
separating gel and 4 % stacking gel were used. Gels were run using a Mini VE 
vertical electrophoresis system (Hoefer, San Francisco USA) with power pack for 
approximately 1 hour at 160 V to allow for complete separation of proteins. The 
size of the purified proteins had to be determined in relation to a set of low 
molecular mass standard proteins (Amersham Biosciences, Vienna Austria) run 
under the same denaturing, reducing conditions. The gels once run were then 
stained with coomasie brilliant blue stain solution for 1 hour. Stain solution is 
composed of 50 % (v/v) methanol, 0.05 % (w/v) coomasie brilliant blue, 10 % 
(v/v) acetic acid and 40 % (v/v) distilled water. Following staining, the gels were 
destained over night in destain solution composed of 5 % ethanol (v/v), 7 % (v/v) 
acetic acid and 88 % (v/v) distilled water. 
 
2.5 SE-HPLC 
The size and homogeneity of purified wild-type Grx2 was assessed using SE-
HPLC. Proteins were separated using a TSKgel G 2000 SWXL size exclusion 
column (Amersham Biosciences, Vienna Austria) with a TSKgel SWXL guard 
column (Amersham Biosciences, Vienna Austria). The buffer used was a 0.1 M 
sodium phosphate buffer, pH 6.7, containing 0.1 M sodium sulphate and 0.05 % 
sodium azide. This buffer was pumped at isocratic pressure through the column 
using a LKB 2150 pump. Protein eluting from the column was detected using a 
spectraseries UV100SP absorbance detector set to record absorbance at 280 nm 
with a sensitivity of 0.02. The absorbance readings were recorded on a chart 
recorder set at a chart speed of 30 cm/hour. A set of gel filtration standard 
proteins (Biorad, Hercules USA) was run under the same conditions as wild-type 
Grx2. 
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2.6 Spectroscopic techniques 
2.6.1 Absorbance spectroscopy  
Absorbance reading were recorded using a Jasco V-550 UV-VIS 
spectrophotometer or a Hewlett Packard model 8452A diode array 
spectrophotometer. The concentration of 2-nitro-5-thiobenzoate anion, 
naphthalenesulphonic acid group (IAEDANS), wild-type Grx2 and Y58W Grx2, 
were determined using absorbance spectroscopy and the Beer-Lambert law, A = 
cl where  is the extinction coefficient, c is the concentration in M and l is the 
pathlength of light in centimetres. The pathlength was 1 centimetre for all 
cuvettes used. The extinction coefficient for the 2-nitro-5-thiobenzoate anion at 
412 nm is 13 600 M-1.cm-1 (Habeeb, 1972) and for naphthalenesulphonic acid 
group of IAEDANS, at 338 nm is 6000 M-1 cm-1 (Hudson and Weber, 1973). 
Then for wild-type Grx2 the extinction coefficient at 280 nm is 21680 M-1. cm-1 
(Vlamis-Garikas et al., 1997). For Y58W Grx2 the extinction coefficient at 280 
nm was determined to be 27670 M-1. cm-1 using the following formula described 
by Perkins (1986): 
280 M
-1
. cm
-1
=[5550 x ( Trp residues)]+[1340 x ( Tyr residues)]+[150 x ( Cys residues )] (1) 
 
2.6.2 Circular dichroism 
Far-ultraviolet circular dichroism spectra and single wavelength readings in the 
far-ultraviolet region, were recorded using a Jasco model J-810 
spectropolarimeter. A 1 mm or 2 mm cuvette was used and readings were taken at 
20 ºC with a data pitch of 0.2 nm, a response of 0.5 sec and a bandwidth of 1 nm. 
For the spectrum readings from 190 to 250 nm, the scanning mode was 
continuous with a scanning speed of 20 nm/min to 100 nm/min and an average of 
10 accumulations taken per sample. When readings were taken at 222 nm 
wavelength only, the readings were taken over a 20 sec time period with an 
average of 3 accumulations for 101 data points each. Buffer contributions were 
subtracted for all data collected.  
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Data obtained was converted to mean residue ellipticity using the following 
formula: 
                                          [] = 100 (signal)/ Cnl                                                (2) 
Where C is the concentration of protein in mM, n is the number of amino acid 
residues in the polypeptide chain and l is the pathlength in cm. The units of mean 
residue ellipticity are deg. cm2. dmol-1.  
 
2.6.3 Fluorescence spectroscopy 
Florescence spectra were recorded using a Perkin Elmer luminescence 
spectrometer model LS 50B. Spectra were recorded for the characterization of 
wild-type Grx2, Y58W Grx2 and AEDANS-labelled Grx2 as well as for urea-
induced equilibrium unfolding of all proteins. The native wild-type Grx2 as well 
as Y58W Grx2 was excited at a wavelength 295 nm with spectra recorded from 
295 nm to 400 nm. The excitation and emission slitwidths for the wild-type Grx2 
were 3 nm and 3.5 nm respectively and 3 nm for both, for Y58W Grx2. 
AEDANS-labelled protein was excited at 338 nm and 295 nm with excitation and 
emission slitwidths of 3 nm. A step size of 200 nm to 300 nm was used for all 
samples. Excitation of the AEDANS probe occurred either directly (excitation at 
338 nm) or by fluorescence resonance energy transfer (excitation at 295 nm). 
Spectra were therefore recorded for AEDANS labelled protein form 295 nm to 
600 nm. The cuvette used for all samples had a 1 cm pathlength, spectra were 
recorded at 20 ºC and buffer contributions subtracted.  
 
2.7 Cysteine modification  
2.7.1 DTNB assay 
Wild-type Grx2 contains two cysteine residues: Cys9 and Cys12 (Xia et al., 
2001). The accessibility and redox state of these residues was assessed with a 
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DTNB assay (Thannhauser et al., 1984). Prior to conducting the assay wild-type 
Grx2 was buffer exchanged using a G-25 Sephadex column into a 50 mM 
phosphate buffer, pH 7, containing 1 mM EDTA and 0.02 % azide. Following 
buffer exchange the DTNB assay was conducted by titration of a solution of 5 µM 
protein, 50 mM phosphate, 1 mM EDTA, 0.02 % azide, pH 7, in the absence and 
presence of 5.4 M guanidine hydrochloride, with 0.22 mM DTNB. The 2-nitro-5-
thiobenzoate anion (absorbs maximally at a wavelength of 412 nm) is released, 
when DTNB reacts with free thiol groups (Habeeb, 1972). The concentration of 
the released 2-nitro-5-thiobenzoate anion was determined spectrophotometrically 
at 20 ºC as described previously (see section 2.6.1).  
Guanidine hydrochloride used in the assay was prepared in the 50 mM phosphate 
buffer, pH 7, containing 1 mM EDTA and 0.02 % azide and filtered. The 
concentration of the guanidine hydrochloride stock solution was determined using 
an Atago R5000 refractometer (Tokyo, Japan). Guanidine hydrochloride was used 
as denaturant as it twice as efficient as urea as a denaturant (Alonso and Dill, 
1991; Myers et al., 1995). 
 
2.7.2 IAEDANS labelling 
The reduced thiol groups of wild-type Grx2 were allowed to react with excess 
IAEDANS for 14 hours at 25 ºC protected from light. This resulted in the 
iodoacetamide group of IAEDANS reacting with the free thiol groups of the 
protein, and the naphthalenesulphonic acid group being covalently attached to the 
protein (Hudson and Weber, 1973). Following attachment any residual IAEDANS 
that was not bound was removed during buffer exchange on a G-25 Sephadex 
column. Labelled Grx2 in a 50 mM phosphate buffer, pH 7, containing 50 mM 
sodium chloride and 0.02 % sodium azide, was then filtered and stored at 4 ºC. 
Unless otherwise stated, all experiments conducted for AEDANS labelled protein 
were in this buffer. The concentration of the naphthalenesulphonic acid groups 
attached to the protein was determined spectrophotometrically as described 
previously (see section 2.6.1).  
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The absorbance of AEDANS (Hudson and Weber, 1973) overlaps with 
absorbance of the protein at 280 nm so therefore the concentration of protein 
could not be determined using the absorbance reading at 280 nm. It was for this 
reason that the concentration of labelled Grx2 was determined using the Bradford 
assay (Bradford, 1976) and bovine serum albumin. The colour change was 
monitored at 595 nm for a set of bovine serum albumin standards of known 
concentration and the labelled Grx2 sample. Concentration of the unknown 
labelled Grx2 was determined by comparison with the standards of known 
concentration. 
 
2.8 Urea-induced equilibrium unfolding  
2.8.1 Determination of reversibility of unfolding  
Equilibrium between the native and the unfolded states of the proteins can only 
occur if the unfolding reactions are shown to be reversible. The reversibility of 
unfolding was determined for wild-type, Y58W and AEDANS-labelled Grx2. To 
determine the reversibly of unfolding, native protein was allowed to unfold in the 
presence of 8 M urea for 1 hour at 20 ºC before refolding was initiated by an 6 
fold dilution of the unfolded protein. Refolding was allowed to proceed for 1 hour 
at 20 ºC prior to both native protein and refolded protein being assessed using far-
ultraviolet circular dichroism (2.6.2) and intrinsic tryptophan fluorescence (2.6.3). 
The buffer for wild-type Grx2 is 50 mM phosphate buffer, pH 7, containing 1 
mM DTT and 0.02 % sodium azide. 
 
All of the urea used for experiments was prepared by the method of Pace (Pace, 
1986) using the buffer for the native protein stock under investigation as solvent. 
Following preparation, the pH of the urea solution was adjusted to pH 7. The 
stock urea solution was then filtered and the concentration of the stock urea 
solution confirmed, to be 10 M, using an Atago R5000 refractometer (Tokyo, 
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Japan) and the method of Pace (Pace, 1986). The 10 M stock solution was then 
frozen at -20 ºC. When the urea was to be used, it was defrosted and used the 
same day. Stock urea was used within a one week of being made. 
 
2.8.2 Urea-induced equilibrium unfolding studies 
Urea-induced unfolding of wild-type Grx2, Y58W Grx2 and AEDANS-labelled 
Grx2, was conducted at a range of urea concentrations from 0 M to 8 M urea. 
Unfolding was conducted at 20 ºC for 1 hour to allow equilibrium to be reached. 
Following 1 hour the samples for the range of urea concentrations, were 
monitored using far-ultraviolet circular dichroism (2.6.2) and fluorescence 
spectroscopy (2.6.3).  
 
Data for all the proteins obtained using all the spectroscopic probes was analysed 
as two-state unfolding processes for monomeric protein. During two-state 
reversible unfolding there is an equilibrium reached between the unfolded species 
(U) and the native species (N):  
                                                   N U                                                          (3) 
During a two-state unfolding transition, only the unfolded and native states that 
are present at significant concentrations (Pace, 1986). Therefore for a two-state 
mechanism: 
                                                         fU + ff =1                                                       (4) 
where ff is the fraction folded or native protein and fU is the fraction unfolded 
protein. At any point during unfolding, there is a contribution to the signal from 
the concentration of both species:  
                                                y = yf ff  + yU fU                                                   (5) 
where y is the signal obtained for the respective spectroscopic probe, ff represents 
the fraction of folded protein, fU represents fraction unfolded protein. In addition 
yf represents the y value for the folded state and can be extrapolated from linear 
pre-transition region of the unfolding data. The symbol yu represents the y value 
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for the unfolded state and can be extrapolated from the linear post-transition 
region of the unfolding data. Combining equations 4 and 5, the fraction of 
unfolded protein can be obtained:  
                                                 fU = (y - yf)/(yU - yf)                                              (6) 
similarly the fraction of folded or native protein can be obtained:  
                                                 ff = (yU - y)/(yU - yf)                                              (7) 
Then the equilibrium constant (Keq) for the unfolding reaction (KU) is:  
                                                   KU = fU / ff                                                          (8) 
So therefore if equations 6 and 7 are substituted into 8: 
                                               KU = (y - yf) / (yU - y)                                             (9) 
and  
                                               G° = - RT ln Keq                                                 (10) 
where G°
 
is the free energy of unfolding, R is the Gas constant, T is temperature 
in Kelvin and Keq is the equilibrium constant for a reaction. 
 
In order to determine G(H20) it is assumed that G° has a linear dependence on 
denaturant concentration [D] for all urea concentrations (Pace, 1986). Therefore,  
                                            G° = G(H2O) –  m [D]                                        (11) 
where G(H2O) represents the free energy required in the absence of denaturant 
to destabilize the protein, m is the m-value for unfolding, and [D] is the 
denaturant concentration. 
Combining equations 9, 10 and 11 and rearranging them gives:  
                       y =[ yf+ yU * e –(G (H20) – m [D])/RT ]/[1 + e –(G (H20) – m [D])/RT ]     (12) 
Data obtained was fitted to equation 12 using SigmaPlot version 8.0 (SPSS 
Science, Chicago, Illinois USA) and the parameters G(H20) and m were 
obtained.   
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2.9 Kinetics 
All kinetic experiments were conducted using a BioSequential SX-18MV 
stopped-flow reaction analyzer from Applied Photophysics (Leatherhead, U.K.) 
The excitation pathlength is 10 mm and the emission pathlength is 2 mm. The 
excitation bandwidth was 2.32 nm to minimize photodecomposition. The 
photomultiplier voltage was set at 600 V for all experiments. The temperature of 
the sample handling unit was maintained at 20 ºC with a fluctuation of not more 
than 0.1 ºC. Analysis of all kinetic data was done using the Applied Photophysics 
software version 4.47 which uses the Levenberg-Marquardt algorithm 
(Marquardt, 1963) for non-linear least squares fitting. 
 
2.9.1 Dead-time determination 
The dead-time of the stopped-flow reaction analyzer during single mixing mode 
(used for single-jump studies), was determined using the reduction of 2,6-
dichlorophenolindophenol (DCIP) by  ascorbic acid  (Tonomura et al., 1978). 
This reaction is pseudo-first order at DCIP concentrations of less than 5 % of the 
ascorbic acid concentration (Tonomura et al., 1978). DCIP was prepared in water 
containing 10 % propanol. Ascorbic acid was prepared by dissolving ascorbic 
acid in 0.02 N hydrochloric acid/0.2 M sodium chloride solution. Dilutions of the 
stock ascorbic acid were prepared using the 0.02 N hydrochloric acid/0.2 M 
sodium chloride solution. The dilutions were prepared in order to produce a range 
of ascorbic acid concentrations from 2 mM to 120 mM. Sodium chloride was 
added in order to minimize the effect of variance of ionic strength (Tonomura et 
al., 1978).  
 
The DCIP solution was rapidly mixed with the range of ascorbic acid 
concentrations, in a 1 : 1 mixing ratio. The pH of the mixing solution was 2. 
Changes in the absorbance as the reactions occurred, was monitored at 524 nm. 
The resulting average of 3 traces was then fitted to a single exponential, excluding 
the first 2 milliseconds data, for each ascorbic acid concentration. The pseudo-
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first order rate constant (kapp) obtained was plotted versus the ascorbic acid 
concentration (Figure 4 A). The plot clearly indicates that the ascorbic acid 
concentrations, 80 mM, 100 mM and 120 mM deviate from a linear trend (Figure 
4 A). These points were therefore excluded from the plot of log of the observed 
absorbance versus the rate constant (Figure 4 B). The equation for the straight line 
fitted to this plot gives the equation: 
 
                                         ln(Aobs) = ln (Atot) – kapp*td                              (13) 
where Aobs is the change in the observed absorbance, Atot is the change in the 
theoretical absorbance, kapp is the apparent rate constant and td is the dead-time of 
the instrument. Therefore for the data obtained, the slope of the log of the 
observed absorbance versus the rate constant data gave a dead-time of 1.1 
milliseconds for the stopped-flow instrument for non-sequential mixing. 
Therefore, no data within 2 milliseconds were fitted for all experiments 
conducted.  
 
The dead-time for the sequential or double mixing mode of the stopped-flow 
reaction analyzer was given in the profiles window generated following a run, 
using the Applied Photophysics software version 4.47. The dead-time was 
displayed along with the exact drive volumes for each mixing event for that run. 
Data within the dead-time for each run were not included in the fitting. The 
average dead-time for the sequential mixing runs was 3 milliseconds. 
 
2.9.2 Kinetics studies 
All kinetic studies were conducted by monitoring changes in the intrinsic 
tryptophan fluorescence emission. The excitation wavelength for all experiments 
was 280 nm, with a cut off filter of 320 nm used to prevent excitation wavelength 
swamping the emission signal. It was shown prior to kinetics experiments for 
wild-type Grx2 and Y58W Grx2 that the proteins do not undergo any 
photodegradation over a period of 1000 seconds and 500 seconds, respectively. 
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Figure 4: Dead-time determination 
(A) pseudo-first order rate constant obtained (kapp) plotted against the ascorbic 
acid concentration for the reaction. Linear fit (solid line) indicating points 
deviating from this trend (B) log of the observed absorbance change versus the 
rate constant for the reaction at specific ascorbic acid concentrations. Linear fit to 
data indicated as a solid line. 
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The baseline values were obtained for 5 µM urea denatured (7.5 M urea) wild-
type Grx2 and Y58W Grx2 and 5 µM native wild-type Grx2 and Y58W Grx2. 
Urea was prepared as stated previously (see section 2.8.1). Kinetic experiments 
were conducted at 20 ºC, three traces were averaged for each urea concentration 
or delay time of unfolding, with the final average trace analysed using the 
Applied Photophysics software. Data were fitted to the following general 
equation: 
                                            Ft =  Fi *exp(-t/) + yo                                          (14) 
where Ft is the total fluorescence amplitude, Fi is the amplitude for the phase i, t is 
time,  is the time constant (is the inverse of the apparent rate constant) and yo is 
the fluorescence amplitude at infinite time. The fit of the data to the general 
equation were shown to be good by residuals plots. 
 
2.9.2.1 Single-jump unfolding and refolding studies 
To produce the unfolding reactions 30 µM native wild-type Grx2 or Y58W Grx2 
was mixed in an asymmetric ratio of 1:5 with buffer containing 6 M to 9 M urea. 
The final unfolding conditions were 5 µM protein and urea concentrations from 5 
M to 7.5 M. Refolding reactions were performed by rapidly mixing unfolded 
protein in a 1:5 ratio with buffer containing 0 to 3.5 M urea. Unfolded protein 
solution of 30 µM wild-type Grx2 or Y58W Grx2 in 6 M urea, was prepared and 
allowed to unfold for 1 hour at 20 ºC. The final refolding conditions following 
mixing were 5 µM wild-type Grx2 or Y58W Grx2 in 1 M to 4 M urea. Urea was 
prepared as for reversibility studies (2.8.1). Unfolding data were fitted to a double 
exponential function while refolding data were fitted to a triple exponential.  
 
2.9.2.2 Kinetic double-jump refolding studies 
A double-jump experiment as the name suggests involves two rapid, successive 
steps. The steps can be either unfolding (delay) followed by refolding or refolding 
(delay) followed by unfolding. The names given to these double-jump 
experiments are refolding double-jump (NUdelayN) or and unfolding 
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double-jump (UNdelayU) experiment respectively. Refolding double-
jump experiments were conducted for wild-type Grx2 only. For the refolding 
double-jump experiment, the first jump or step is a rapid unfolding of the protein. 
Unfolding reactions were carried out with initial urea concentrations of 7.7 M 
urea and 8.4 M urea rapidly mixed with 105 µM wild-type Grx2 in a ratio of 
1:2.5. The final conditions for the unfolding reactions were 30 µM unfolding 
wild-type Grx2 with 5.5 M urea or 6 M urea. The protein is allowed to unfold in 
an ageing loop for a specified delay times ranging from 10 seconds to 500 
seconds before refolding was initiated by a 5 fold dilution of the unfolding 
reaction. The resultant refolding conditions of 5 µM wild-type Grx2 in 0.95 M 
residual urea or 1 M residual urea, were produced and monitored by intrinsic 
tryptophan fluorescence. For all conditions specified, the 5.5 M urea unfolding 
conditions were stated first, followed by the 6 M urea conditions. As the refolding 
was initiated during the double-jump experiments, the ageing loop, where the 
unfolding reactions take place, was flushed with 5.5 M urea or 6 M urea solution, 
depending on the concentration used for unfolding.  
 
In order to perform the double-jump experiments the stopped-flow reaction 
analyzer was set up for sequential mixing. Refolding data were fitted to equation 
14 (2.9.2) for double exponential as well as triple exponential fits depending on 
the delay time of unfolding. For 5.5 M double-jump experiments, refolding data 
for unfolding delay times shorter than 45 sec were fitted to a double exponential 
and for delay times greater than 45 sec to a triple exponential. Similarly for the 6 
M double-jump data for unfolding delays of less than 30 seconds were fitted to a 
double exponential and for data of 30 sec delay times and longer a triple 
exponential were fitted. The fit of the data were shown to be good by residuals 
plots. 
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2.9.2.3 Kinetics of refolding in the presence of hFKBP-12 
Double-jump refolding experiments using 6 M urea for unfolding as well as 
single-jump refolding experiments were conducted in the presence of the PPI, 
hFKBP-12. The double-jump refolding experiments with hFKBP-12 were 
conducted as stated before for 6 M urea unfolding delay experiments (see section 
2.9.2.2) except 1 µM hFKBP-12 was added to the refolding buffer.  
 
Single-jump refolding experiments in the presence of hFKBP-12 were conducted 
as stated previously (see section 2.9.2.1) only hFKBP-12 was added to the 
refolding buffer (range of concentrations form 0 µM to 3.6 µM). The final 
refolding conditions were 5 µM wild-type Grx2, 1 M Urea and 0 µM to 3 µM 
hFKBP-12. Resultant average refolding traces were fitted to a triple-exponential 
and the fit was shown to be the best by residuals plots.   
 
2.10 Software for structural analysis, sequence analysis and 
data fitting  
Unless otherwise stated all non-linear and linear least squares fitting of data were 
done using Sigma Plot (version 8.0) (SPSS Science, Chicago, Illinois USA). 
Protein illustrations were produced using Swiss PDB viewer (ver 3.7) (Guex and 
Peitsch, 1997). The wild-type and Y58W Grx2 DNA sequences obtained were 
viewed using the program Chromas version 1.45 (32 bit) 
(http://www.technelysium.com.au/chromas.html; Technelysium Pty. Ltd., 
Helensvale, Australia). The structure-based sequence alignment (Figure 1) of the 
GST family of structurally related proteins was done using Cn3D version 4.1 
(Wang et al., 2000) which incorporates the structure-based sequence alignment 
tool SALTO (Kann et al., 2005) as well as the alignment refinement algorithm 
REFINER (Chakrabarti et al., 2006).  
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3 RESULTS 
3.1 Mutagenesis to produce Y58W Grx2 
Using wild-type Grx2 plasmid DNA as a template, the Y58W mutant Grx 2 was 
created by site-directed mutagenesis (section 2.2). Sequencing of the resultant 
plasmid DNA indicated that the desired mutation had been incorporated and no 
additional mutations were incorporated during mutagenesis (Figure 5). 
 
3.2 Size of wild-type and Y58W Grx2 
SDS-PAGE was used to determine the size and purity of wild-type and Y58W 
Grx2. Both proteins were shown to be pure following purification and are 25 kDa 
in size (Figure 6). The size of the proteins was determined by comparing the 
distance they migrate in comparison to the distance the low molecular mass 
proteins migrate under the same denaturing, reducing conditions (Figure 6). A 
size of 25 kDa is consistent with the published results for wild-type Grx2 (Xia et 
al., 2001; Vlamis-Gardikas et al., 1997). It was confirmed that the native non-
denatured size of wild-type Grx2 is 25 kDa by size exclusion high pressure liquid 
chromatography (Figure 8). The results also indicate that glutaredoxin 2 is 
monomeric, this result is in agreement with the published NMR determined 
structure of reduced Grx2 (Xia, et al., 2001).  
 
3.3 Active site cysteine modification of wild-type Grx2 
3.3.1  Thiol groups of wild-type Grx2  
DTNB assays are used to determine the accessibility to solvent and redox state of 
cysteine residues (Habeeb, 1972). Wild-type Grx2 contains two cysteine residues 
(Cys9 and Cys12) (Xia, et al., 2001).  
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Figure 5: Y58W sequencing conformation 
The sequences obtained from sequencing were viewed using the program 
Chromas version 1.45 (32 bit) (http://www.technelysium.com.au/chromas.html; 
Technelysium Pty. Ltd., Helensvale, Australia). Shown here is a small segment of 
the sequence. The wild-type TAT codon for a tyrosine was replaced with the 
TGG codon for a tryptophan. No additional mutations occurred during the 
mutagenesis.  
 Wild-type sequence TAT (codon for Y)
Mutant sequence TGG (codon for a W) replaces TAT
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Figure 6: SDS-PAGE analysis wild-type Grx2 and Y58W Grx2 
Discontinuous SDS-PAGE gels and calibration curves for (A) wild-type Grx2 and 
(B) Y58W Grx2. Gels are marked according to the samples that were loaded. 
Pellet and supernatant samples for Y58W Grx2 are shown in B. The  marker lane 
correspond to the low molecular mass marker sample that was run, the size of the 
marker proteins are indicated on the gel and their names and sizes given on the 
calibration curves. Wild-type Grx2 and Y58W Grx2 both migrated a distance 
which correspond to a size of 25 kDa. For the respective calibration curves the 
position of both purified wild-type Grx2 and Y58W Grx2 marked on the gels (+).  
 
Distance migrated(mm)
5 10 15 20 25 30 35 40 45 50 55 60 65
Lo
g 1
0 
M
o
le
cu
la
r 
M
a
ss
4.2
4.4
4.6
4.8
5.097kDa
66kDa
45kDa
30kDa
20.1kDa
14.4kDa
G
rx2
M
a
rk
er
A. wild-type Grx2
Phophorylase b (97 kDa)
Albumin (66 kDa)
Ovalbumin (45 kDa)
Carbonic anhydrase (30 kDa)
Trypsin inhibitor (20 kDa)
-Lactalbumin (14.4 kDa)
Purified Grx2
Lo
g 1
0 
M
o
le
cu
la
r 
M
a
ss
G
rx2
M
a
rk
er
Distance migrated (mm)
0 10 20 30 40 50 60 70 80
Lo
g 1
0 
M
o
le
cu
la
r 
M
a
ss
4.0
4.2
4.4
4.6
4.8
5.0
5.2
-galactosidase (116 kDa)
Bovine serum albumin (66 kDa)
Ovalbumin (45 kDa)
Lactate dehydrogenase (35 kDa) Y58W Grx2
Restriction endonuclease Bsp981 (25 kDa)
-lactoglobulin (18 kDa)
Lysozyme (14 kDa)
116 kDa
66 kDa
45 kDa
35 kDa
25 kDa
18 kDa
14 kDa
M
a
rk
er
Y
58W
G
rx2
Y
58W
G
rx2
P
ellet
S
up
ern
ata
nt
B. Y58W Grx2
Lo
g 1
0 
M
o
le
cu
la
r 
M
a
ss
M
a
rk
er
Y
58W
G
rx2
Y
58W
G
rx2
P
ellet
S
up
ern
ata
nt
Lo
g 1
0 
M
o
le
cu
la
r 
M
a
ss
M
a
rk
er
Y
58W
G
rx2
Y
58W
G
rx2
P
ellet
S
up
ern
ata
nt
  
 
45 
 
Retention time (min)
16 18 20 22 24 26 28 30 32
Lo
g 1
0 
M
o
le
cu
la
r 
M
a
ss
4.0
4.2
4.4
4.6
4.8
5.0
5.2
5.4
5.6
5.8
6.0
Retention time (min)
A
bs
o
rb
a
n
ce
 
28
0n
m
Thyroglobulin (670 kDa)
Gamma globulin (158 kDa)
Ovalbumin (44 kDa)
Myoglobin (17 kDa)
B
A
Purified Grx2
Lo
g 1
0 
M
o
le
cu
la
r 
M
a
ss
A
bs
o
rb
a
n
ce
 
28
0n
m
 
Figure 7: Size exclusion high pressure liquid chromatography  
The (A) elution profile of wild-type Grx2 detected by monitoring the absorbance 
at 280 nm of eluent. The retention times along with the molecular masses of the 
standard proteins was used to construct a (B) calibration curve, from the curve it 
was shown that the retention time of Grx2 corresponds to a molecular mass of 25 
kDa. The names and sizes of the standard proteins as well as purified wild type 
Grx2 are indicated. 
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For the DTNB assay a concentration of 5 µM native and guanidine hydrochloride 
denatured wild-type Grx2, bound DTNB releasing 10 µM and 8.2 µM  of 2-nitro-
5-thiobenzoate anion, respectively (concentration determined 
spectrophotometrically see section 2.6.1). The results of the DTNB assay 
indicated that both of the cysteine residues of wild-type Grx2 reacted with the 
DTNB and therefore wild-type Grx2 has two free thiol groups that are maintained 
in their reduced state by the presence of 1 mM DTT in the storage buffer. So 
although the active site is buried in the interface between the two domains the 
DTNB assay indicates that the active site cysteine residue are still accessible to 
small molecules, which is consistent with published data (Aslund, et al., 1994; 
Vlamis-Gardikas, et al., 1997; Xia, et al., 2001). The reason the concentration of 
released 2-nitro-5-thiobenzoate anion was lower for the denatured protein could 
be due to possible oxidation of the thiol groups or a loss of thiol groups that 
occurs when guanidine hydrochloride is in a phosphate buffer (Habeeb, 1972).   
 
3.3.2 IAEDANS-labelling of wild-type Grx2 
Both of the cysteine residues of native wild-type Grx2 were shown to be 
accessible to solvent (see above section 3.3.1) and in their reduced state when 
stored in DTT containing buffer. These residues could therefore be reduced with 
1,5-I-AEDANS (iodoacetyl-aminoethyl)-5-naphthylamine-1-sulfonic acid. Once 
the residues had been labelled a Bradford assay (Bradford, 1976) was used to 
determine the concentration of the stock solution of labelled Grx2 to be 80 µM. 
The AEDANS concentration in the protein stock solution was 77 µM as 
determined spectrophotometrically (section 2.6.1). The results therefore indicated 
that although both cysteine residues are accessible to DTNB only one of the 
cysteine residues of wild-type Grx2 was labelled with AEDANS. The most likely 
labelled cysteine being Cys9 as it is more solvent accessible than Cys12 in the 
native structure of wild-type Grx2 (Xia et al., 2001). An alignment and structural 
assessment of similarities between glutaredoxins and thioredoxins indicated that 
the redox sulphur atoms in these proteins are accessible from one side of the 
molecule but not the other (Eklund et al., 1984). This could also explain how only 
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one of the cysteine residues was labelled in glutaredoxin 2 as it shares a similar 
active site sequence to glutaredoxin 1 and 3 (Vlamis-Gardikas et al., 1997) as 
well as catalyses some of the same reactions (Lundstrom-Ljung et al., 1999).  
 
3.3.3 Secondary structural characterization 
The amide bond linking amino acids in proteins acts as the most abundant 
chromophore absorbing circularly polarized light in the far-ultraviolet region 
(Woody, 1995). The circular dichroism spectra for proteins, in the far-ultraviolet 
region have characteristic features based on the secondary structure adopted by 
the proteins (Woody, 1995). Therefore it was used to assess the secondary 
structural nature of wild-type Grx2, AEDANS labelled Grx2 and Y58W Grx2. 
Proteins composed mainly of -helices have the strongest and most characteristic 
spectrum with distinct troughs or minima at 208 nm and 222 nm, with a peak at 
190 nm (Woody, 1995). Spectra for wild-type and Y58W Grx2  display these 
distinct spectra (Figure 8) indicating that the proteins are composed 
predominantly of -helices and that no gross secondary structural changes had 
occurred to Y58W Grx2 upon substitution of a tryptophan for a tyrosine residue. 
The helical secondary structural nature of Grx2 is in agreement with the NMR 
determined structure of wild-type Grx2 (Xia et al., 2001) as well as the structural 
homologous GST proteins human GST A1-1 (Wallace and Dirr, 1999), Sigma 
glutathione transferase (Stevens et al., 1998) and Ure2 protein (Thual et al., 
2001), which display similar far-ultraviolet circular dichroism spectrum.  
 
The signal for the native AEDANS labelled protein was not the same as for native 
wild-type Grx2 and showed a loss of -helical structure (Figure 8), this would 
indicate that gross structural changes occurred to the protein upon labelling. The 
loss in secondary structure seen for the labelled protein is almost as severe as the 
loss that occurs when the wild-type and Y58W Grx2 are incubated in 7 M urea 
(Figure 8). Far-ultraviolet circular dichroism spectra for unordered polypeptides 
have spectra that have weak spectra at wavelengths longer than 200 nm, the weak 
spectra could be either positive or negative (Woody, 1995).   
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Figure 8: Far-ultraviolet circular dichroism spectra  
Spectra shown for 5 µM (—) native wild-type Grx2, (—) native Y58W Grx2 and 
for 5µM urea denatured (7 M urea) (—) wild-type Grx2 and (—) Y58W Grx2. 
The spectrum for (—) 20 µM native labelled Grx2 is also included. The buffer 
was diluted 10 fold for the native far-ultraviolet circular dichroism spectra for 
wild-type and Y58W Grx2 in order to prevent the salt in the buffer causing a 
noisy signal.  
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3.3.4 Tertiary structural characterization of Grx2 
Phenylalanine, tyrosine and tryptophan are the dominant fluorescent amino acids 
in proteins, the most dominant of the three being tryptophan which absorbs light 
maximally at wavelengths longer than 295 nm (Lakowicz, 1999). Glutaredoxin 2 
contains two tryptophan residues (Xia et al., 2001) (see section 1.6 and Figure 3), 
while the mutant protein (Y58W) contains three tryptophan residues. The 
emission spectra for native wild-type and Y58W Grx2 display fluorescence 
emission maxima at a wavelength of 345 nm (Figure 9). Structurally related GST 
proteins with buried tryptophan residues display emission maximum for the 
native proteins at a wavelength of 335 nm (Hornby et al., 2000; Hornby et al., 
2002; Kaplan et al., 1997; Luo et al., 2002) therefore the tryptophan residue of 
Grx2 in comparison must be slightly exposed tryptophan residues in the native 
structure. The slight solvent exposure of the tryptophan residues for the wild-type 
protein can be confirmed by inspection of the NMR determined structure (see 
section 1.6) (Xia et al., 2001). The emission maximum for several proteins that 
contain tryptophan residues  red shifts from the native state emission maximum to 
a denatured state emission maximum of 355 nm (Teale, 1960). This characteristic 
red shift in the maximum wavelength as well as a decrease in the intensity occurs 
for wild-type and Y58W Grx2 in the presence of denaturing concentrations of 
urea (Figure 9). The indole ring of tryptophan residues (Lakowicz, 1999) as well 
as the extrinsic probe AEDANS (Hudson and Weber, 1973) are sensitive to 
changes in the environment as has been show by the changes in emission maxima 
for native and denatured proteins. It is for this reason that the intrinsic tryptophan 
residues as well as extrinsic AEDANS probe can be used to monitor local 
structural changes for Grx2 during (un)folding. The native and denatured labelled 
protein exhibited an emission maximum of 465 nm and 485 nm respectively, 
regardless of the excitation wavelength (either 295 nm or 338 nm) (Figure 10). 
The emission maxima of both the native and denatured labelled protein are 
characteristic of the AEDANS probe because the emission of the tryptophan 
residues overlaps with the absorbance wavelength of the AEDANS (Hudson and 
Weber, 1973) and energy transfer occurs (Lakowicz, 1999).  
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Figure 9: Fluorescence spectra for wild-type and Y58W Grx2 
Emission spectra were taken of 5 µM (—) native wild-type Grx2, (—) native 
Y58W Grx2 and 5µM urea denatured (7 M urea), (—) wild-type Grx2 and (—) 
Y58W Grx2, upon excitation with light of 295 nm wavelength.  
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Figure 10: Fluorescence spectra AEDANS labelled Grx2 
The emission spectra were recorded for 10 µM native AEDANS labelled Grx2 
excited at (—) 295 nm and (····) 338 nm and for 10 µM denatured (8 M urea) 
AEDANS labelled Grx2 excited at (—) 295 nm and (····) 338 nm. 
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An increase of 20 % in the intensity of the emitted signal for the native mutant 
protein indicates the presence of an additional intrinsic tryptophan fluorophore for 
the mutant protein. There is however no changes in the position of the emission 
spectrum maxima for the native and denatured mutant protein, respectively.  
 
3.4 Conformational stability  
3.4.1 Reversibility of unfolding  
Wild-type Grx2, Y58W Grx2 and labelled Grx2 were allowed to unfold in the 
presence of urea, the urea was then diluted and to allow refolding of the proteins. 
Then the refolded protein as well as native protein was characterized using the 
structural probes far-ultraviolet circular dichroism and fluorescence (Figure 11 
and Figure 12 respectively). It was shown for wild-type, Y58W, and AEDANS 
labelled Grx2 that the far-ultraviolet circular dichroism spectra for the refolded 
and native proteins were almost identical (Figure 11). Both 208 nm and 222 nm 
are characteristic troughs in the spectra of the -helical proteins (see section 
3.3.3). For the secondary structural probe (far-ultraviolet circular dichroism) the 
signal to noise ratio was best at a wavelength of 222 nm in the presence of urea, it 
was for this reason that it was chosen and not the signal at a wavelength of 208 
nm. The percentage recovery as determined using the 222 nm signal values for 
wild-type, Y58W and AEDANS-labelled Grx2 were calculated to be 96 %, 100 % 
and 100 % respectively. Although the ellipticity values at 222 nm gave a recovery 
of 100 % for AEDANS labelled protein, this may not be a very accurate measure 
as the signal is very noisy for the far-ultraviolet region due to structural changes 
(Figure 8).  
 
Intrinsic tryptophan fluorescence was also used as a tertiary structural probe for 
native and refolded proteins (Figure 12). The change in the signal only at 345 nm 
is monitored for wild-type and Y58W Grx2. For the labelled protein intrinsic 
tryptophan fluorescence as well as extrinsic AEDANS fluorescence was used to  
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Figure 11: Reversibility of unfolding monitored by far-ultraviolet circular 
dichroism 
The far-ultraviolet circular dichroism spectra for (A) wild-type Grx2 (B) Y58W 
Grx2 and (C) for AEDANS-labelled Grx2. Spectra for native proteins are 
represented by the black lines and spectra for the refolded proteins are represented 
by grey lines. The final concentration for native and refolded proteins was 5 µM.  
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Figure 12: Reversibility of unfolding monitored by intrinsic and extrinsic 
fluorescence 
Fluorescence emission spectra for (A) wild-type, (B) Y58W and (C) AEDANS-
labelled Grx2 were recorded for native proteins (black) and refolded proteins 
(grey). Florescence emission spectra for all proteins was conducted for a final 
concentration of 5µM protein. For wild-type and Y58W Grx2 the excitation 
wavelength was 295 nm only. The AEDANS-labelled protein however had an 
additional extrinsic probe that was used. The AEDANS probe was excited with 
light of 338 nm wavelength, the spectra for the extrinsic probe are displayed as 
dotted lines.  
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assess refolded protein. The fluorescence measurements were taken for the 
labelled protein samples at 465 nm regardless of where the excitation wavelength 
was either 295 nm or 338 nm. Based on the values obtained from the specified 
florescence wavelengths for wild-type, Y58W and AEDANS-labelled Grx2 the 
percentage recoveries were calculated to be 100 %, 97 % and 80 % (both extrinsic 
and intrinsic fluorescence probes). The percentage recoveries are expected for the 
fluorescence spectra of the proteins. The wild-type and Y58W Grx2 native and 
refolded spectra in close agreement while there is a decrease in the intensity of 
emission maxima for the labelled protein (Figure 12). 
 
The fact that the unfolding reaction is reversible for wild-type, Y58W and 
AEDANS-labelled Grx2 indicates that there are no off-pathway folding pathways 
during refolding that result in aggregation of protein and therefore a loss of 
recovery of native protein. A high refolding recovery is important for the detailed 
characterization of equilibrium unfolding data as well as the analysis of the 
kinetic data to provide information leading toward proposed mechanisms for 
unfolding and refolding. 
 
3.4.2 Urea-induced equilibrium unfolding  
A set of unfolding reactions for a range of urea concentrations, from 0 M urea to 8 
M urea, were set up and allowed to reach equilibrium (1 hour). The resulting 
equilibrium reactions were monitored by the structural probes far-ultraviolet 
circular dichroism as well as intrinsic tryptophan fluorescence and extrinsic 
AEDANS fluorescence (Figure 13). The probes assess the structure of the 
predominating species present in the equilibrium mixture at the set urea 
concentration (Pace, 1986). As for the reversibility of all the proteins, for both 
far-ultraviolet circular dichroism and fluorescence the wavelength chosen to 
monitor unfolding is where there is the maximum change in the signal between 
the native and unfolded state (as was used in 3.4.1 for recovery percentage 
calculation). The data obtained were then analysed and a single sigmoidal curve  
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Figure 13: Urea-induced equilibrium unfolding  
Unfolding reactions at equilibrium for (A) 5 µM wild-type Grx2 and (B) 5 µM 
Y58W Grx2 were monitored by () far-ultraviolet circular dichroism ellipticity at 
222 nm and () intrinsic tryptophan fluorescence (excitation wavelength of 295 
nm and the emission monitored at 345 nm). Unfolding reactions at equilibrium for 
(C) 10 µM  AEDANS-labelled Grx2 were monitored by fluorescence, emission at 
465 nm with excitation at () 295 nm and () 338 nm, respectively. The 
secondary structural probe far-ultraviolet circular dichroism was also used to 
monitor changes for the labelled protein with the ellipticity at () 222 nm used to 
determine the fraction of unfolded protein at each urea concentration. Data were 
normalised to the fraction of unfolded protein. Solid lines represent two-state 
sigmoidal fit to the data.  
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fit to the data for wild-type and Y58W Grx2 as well as AEDANS-labelled Grx2 
(Figure 13). The unfolding data for both wild-type Grx2 and Y58W Grx2, shows 
that the predominant species of the protein is the native state at urea 
concentrations of 0 M to 4 M. The transition region begins at 4 M urea and ends 
at 5 M urea. From 5 M urea to 8 M urea the protein is unfolded. With the single 
sigmoidal fit being a good one, it indicates that the unfolding of wild-type and 
Y58W Grx2 is a two-state process with no significant population of intermediates 
present. The unfolding as monitored by the tertiary local structural probe intrinsic 
tryptophan fluorescence and the global secondary structural probe far-ultraviolet 
circular dichroism overlay and are in agreement. This adds further support for this 
conclusion that equilibrium unfolding of wild-type and Y58W Grx2 is a two-state 
process with no stable equilibrium intermediates accumulating during unfolding.  
 
The unfolding is different for AEDANS-labelled Grx2 as the predominant species 
of the protein is the native state only up until 2 M urea. At 2 M urea, the transition 
region begins and this region ends at 3.5 M to 4 M urea depending on the probe. 
From 4 M urea to 8 M urea, labelled Grx2 is completely unfolded. The intrinsic 
tryptophan and the extrinsic AEDANS probes for the labelled protein agreed with 
one another but not with the far-ultraviolet circular dichroism data (Table 2). This 
indicates that during the unfolding of AEDANS-labelled protein an intermediate 
could be present. The non-coincidence could also reflect the less than 100 % 
reversibility of the unfolding reaction (see section 3.4.1). The differences detected 
between probes cannot be due to concentration errors because the same samples 
were used for both probes. 
 
The parameters obtained from fitting the all equilibrium unfolding data for wild-
type, Y58W and AEDANS-labelled Grx2 are summarized in Table 2. The 
G(H2O), m and Cm value obtained for the Y58W Grx2 are also in close 
agreement with those obtained for wild-type Grx2 whereas the values obtained for 
AEDANS-labelled Grx2 differ greatly. The significance of the values obtained for 
the labelled protein will be discussed later (4.1).  
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Table 2: Parameters obtained for equilibrium unfolding  
The equilibrium unfolding of wild-type Grx2, Y58W Grx2 and labelled Grx2 were monitored 
using far-ultraviolet circular dichroism as well as fluorescence. Intrinsic tryptophan fluorescence 
was the tertiary structural probe used for wild-type Grx2 and Y58W Grx2. The tertiary structural 
probes used for labelled protein were direct excitation of the extrinsic AEDANS probe as well as 
fluorescence energy transfer for the tryptophan residues to AEDANS. Data obtained from all 
probes were fitted to a two-state model.  
Wild-type glutaredoxin 2 
 
Parameters 
Far-ultraviolet 
circular dichroism 
Intrinsic 
tryptophan 
fluorescence 
Average 
G(H2O) (kcal.mol-1) 12.0 (± 1.0) 12.5 (± 1.1) 12.3 
m (kcal mol-1 M-1 urea) 2.7 (± 0.2) 2.79 (± 0.3) 2.74 
Cm (M urea) 4.4 4.4 4.4 
 
Y58W glutaredoxin 2 
 
Parameters 
Far-ultraviolet 
circular dichroism 
Intrinsic 
tryptophan 
fluorescence 
Average 
G(H2O) (kcal.mol-1) 9.0 (± 1.2) 9.9 (± 1.1) 9.5 
m (kcal mol-1 M-1 urea) 2.1 (± 0.3) 2.3 (± 0.3) 2.2 
Cm (M urea) 4.3 4.3 4.3 
 
AEDANS-labelled glutaredoxin 2 
 
Parameters 
Far-ultraviolet 
circular dichroism 
AEDANS 
fluorescence 
Fluorescence 
energy transfer 
Average 
G(H2O) 
(kcal.mol-1) 
6.8 (± 0.9) 4.6 (± 1.1) 4.6 (± 0.7) 5.4 
m (kcal.mol-1           
.M-1 urea) 
2.1 (± 0.3) 1.6 (± 0.4) 1.6 (± 0.2) 1.8 
Cm (M urea) 3.2 2.9 2.9 3.0 
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3.5 Single-jump kinetic studies 
Intrinsic tryptophan fluorescence was chosen as a structural probe for the changes 
occurring during (un)folding of wild-type and Y58W Grx2. It was chosen because 
there is changes in the intensity of the emission signal of the intrinsic tryptophan 
residues on denaturation (quenching) or renaturation (enhanced) of the proteins 
such that the unfolding or refolding of the protein can be monitored (see Figure 
9).  
 
The excitation wavelength chosen for the fluorescence was 280 nm, as it results in 
greater absorbance and excitation of the tryptophan residues. When the protein is 
excited with light of a wavelength of 280 nm, resonance energy transfer occurs 
from the tyrosine residues to the tryptophan residues and the emission spectrum 
characteristic of a tryptophan emission spectrum is observed (Lakowicz, 1999). In 
addition, the cut off filter (320 nm) eliminates any detectable contribution of the 
tyrosine residues (emission at 303 nm in water) (Lakowicz, 1999). The signal 
output for the stopped-flow reaction analyzer is in volts and therefore provides 
fluorescence intensity over a range of wavelengths (greater than 320 nm) not at a 
particular wavelength. 
  
3.5.1 Unfolding kinetics 
From the equilibrium unfolding data it can be seen that at urea concentration of 5 
M to 8 M urea the predominating species is that of unfolded protein for both wild-
type and Y58W Grx2 (Figure 13). Kinetic unfolding experiments were therefore 
conducted over this range of urea concentrations, as no refolding should occur, 
and the resultant traces analysed. A double exponential fit was shown by residuals 
plot to be the best fit for both wild-type and Y58W Grx2 (Figure 14). These two 
phases account for all the amplitude change during the unfolding reactions as the 
unfolding kinetic traces extend from the native protein baseline to the unfolded 
protein baseline.  
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Figure 14: Unfolding kinetics traces 
The average of () three kinetic unfolding traces (7.5 M urea) for 5 µM (A) wild-
type Grx2 or (B) Y58W Grx2 in the phosphate dialysis buffer, ph 7. The 
excitation wavelength was set at 280 nm with the emission intensity change 
monitored with a 320 nm cut off filter at 20 ºC. Data were fitted to a double 
exponential as indicated by the solid black line. Residuals indicate the fit is good 
one. The red arrow indicates the position of the average value for the native 
baseline and the blue arrow the position of the average value for the unfolded 
baseline 
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The percentage amplitude change for each phase for the wild-type and mutant 
proteins was then plotted against the urea concentration for that unfolding 
reaction (Figure 15 A). Changes in the amplitude for wild-type Grx2, over the 
range of urea concentrations from 5 M to 7.5 M urea are complex, with the fast 
phase amplitude decreasing from 26 % at 5 M urea to 15 % at 5.25 M urea before 
increasing to 86 % at 5.75 M urea. From 5.75 M urea to 7.5 M urea it remains 
relatively constant. The amplitude changes are different for the fast phase of the 
mutant protein with the amplitudes increasing from 50 % at 5 M urea to 90 % at 
5.6 M urea, from 5.6 M urea the amplitude remains constant. Similarly the change 
in the percentage amplitude of the slow phases of unfolding over the range of urea 
concentrations is complex for wild-type Grx2. The slow phase amplitudes 
increase from 74 % at 5 M urea to 85 % at 5.25 M urea before decreasing to a 
percentage of 14 % at 5.75 M urea. From 5.75 M urea to 7.5 M urea the 
amplitudes remain relatively constant. Y58W Grx2 however displays a different 
pattern for the changes in the amplitudes of the slow phase. The slow phase 
amplitudes decrease from 45 % at 5 M urea to 10 % at 5.6 M urea. From 5.6 M 
urea it remains roughly 10 % to a urea concentration to 7.5 M. 
 
Wild-type Grx2 at 7.5 M urea displays a fast phase that has a time constant 
(inverse of the rate constant) of 1.4 sec and the slow phase has a time constant of 
140 sec. Similarly, Y58W Grx2 has two phases of unfolding. At 7.5 M urea, the 
time constant of the fast phase is 210 milliseconds and for the slow phase is 150 
seconds. The kinetic unfolding of human GST A1-1 a structurally related protein, 
as monitored by tryptophan fluorescence also displays two kinetic unfolding 
phases with comparable time ranges to the two phases of Grx2 (Wallace et al., 
1998). The logarithm of the rates of the fast and slow phases of unfolding for both 
the wild-type and Y58W Grx2 were plotted against the respective urea 
concentration at which they were obtained (Figure 15 B). Wild-type Grx2 
displays complex urea dependence for the rates of both the fast phase and the 
slow phase of unfolding while Y58W Grx2 does not. For both proteins, the slow 
phase displays low urea dependence while the fast phases high urea dependence  
  
 
62 
 
Urea concentration (M)
5.00 5.25 5.50 5.75 6.00 6.25 6.50 6.75 7.00 7.25 7.50 7.75
A
m
pl
itu
de
0
20
40
60
80
100
A
Urea concentration (M)
5.00 5.25 5.50 5.75 6.00 6.25 6.50 6.75 7.00 7.25 7.50 7.75
Lo
g 
k u
-3
-2
-1
0
1
B
 
 
Figure 15: Affect of urea on the fast and slow phases of unfolding 
 The dependence of (A) amplitude and (B) log of the rates of unfolding on urea 
for wild-type Grx2 (closed symbols) and Y58W Grx2 (open symbols). The 
dependencies of the () fast phase and the () slow phase of unfolding were 
obtained from fitting a double exponential to the traces obtained for each urea 
concentration. The solid (wild-type Grx2) and dashed (Y58W Grx2) lines 
represent a linear fit to the rate data (see Table 3 for values). 
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Table 3: Affect of varying final urea concentration on unfolding 
 The logarithm of the rates of the fast and slow phases of unfolding for different final urea concentrations is displayed in Figure 15. Linear 
regression analysis was done for the entire set of data for the slow phase of the mutant protein (R2=0.60) and the fast phase (R2=0.97) for the 
mutant protein. The data set for the fast phase (R2=0.99) and the slow phase (R2=0.12) of unfolding for the wild-type protein was only 
analysed form 5.5 M urea and 5.6 M urea respectively, to 7.5 M urea. Fitting the data to a linear function results in obtaining the parameters 
of mu (change in solvent accessibility during unfolding) and ku(H2O) (apparent unfolding rate in the absence of denaturant) (Tanford, 1970), 
presented in this table . 
 
Wild-type Grx2 Y58W Grx2  
Parameter Fast phase Slow phase Fast phase Slow phase 
mu  (kJ mol-1/ M urea) 1.6 (± 0.077) 0.12 (± 0.16) 1.7 (± 0.10) 0.19 (± 0.055) 
ku(H2O) (ms-1) 7.6 x 10-3 (± 3.0 x 10-4) 3.6 (± 0.59) 0.044 (± 0.0025) 23 (± 1.9) 
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however, the urea dependence for the wild-type protein of both the fast phase and 
slow phase changes 5.5 M urea. It is also interesting to note that the wild-type 
data for 5 M and 5.25 M urea align with the mutant proteins data. Linear 
regression analysis was conducted for the complete set of data for the fast phase 
and the slow phase of the mutant protein and was only done for data from 5.5 M 
and 5.6 M urea to 7.5 M urea for the fast and slow phases of the wild-type protein 
respectively. The data were fitted to the following equation (Tanford, 1970): 
log ku=log ku(H20)+mu[Urea]                                       (15) 
where ku  is the apparent first order rate constant for unfolding. The mu values 
(change in solvent accessibility during unfolding) and the apparent rates of 
unfolding in the absence of water (ku(H2O)) reported in Table 3. The units for the 
mu values were determined by multiplying the values by the product of the gas 
constant (R = 8.31 J k-1 mol-1) and the temperature (298 K). 
 
3.5.2 Refolding kinetics 
The equilibrium unfolding data indicates that at urea concentrations of 0 M to 4 
M, the predominating species is that of native protein for both wild-type Grx2 and 
Y58W Grx2 (Figure 13). Kinetic refolding experiments were therefore conducted 
over the range of urea concentrations from 1 M to 4 M at these concentrations the 
unfolding reaction should not occur as these are strongly refolding conditions. 
Refolding was monitored by intrinsic tryptophan fluorescence and an average 
trace obtained from three refolding traces per urea concentration. The average 
trace was then fitted to a triple exponential, the fit was shown to be good by the 
random distribution of points on the residuals plot (Figure 16). The refolding 
reaction monitored and fit to a triple exponential was shown to account for the 
total amplitude change from unfolded protein to native protein, by the position of 
the baselines (Figure 16). Therefore, the folding of both wild-type Grx2 and 
Y58W Grx2 is composed of 3 phases: fast, medium and slow. Fitting the data 
gave time constants, the inverse of the rate constants as follows: for the fast phase 
61 milliseconds, the medium phase 0.79 seconds and the slow phase 180 seconds,  
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Figure 16: Refolding kinetics traces for 1M residual urea 
The average of () 3 refolding kinetic traces for 5 µM (A) wild-type Grx2 and (B) 
Y58W Grx2 in buffer, pH 7 containing 1 M  urea. Refolding traces were recorded 
for the first 4 sec (insets) with the red arrows indicating the unfolded baseline. 
Following the first 5 sec of refolding a slow phase of refolding occurs for the 
remaining 1000 sec, the native protein baseline is indicated with a blue arrow. 
Refolding was conducted at 20 ºC and the average data traces for three reactions 
were fitted to a double exponential (inset) and a single exponential (both indicated 
by black lines). The residuals plots indicate both fits are good. 
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this was all for  refolding in the presence of 1 M residual urea for wild-type Grx2. 
The corresponding amplitude changes for wild-type Grx2 are 50 %, 17 % and 33 
% for the fast, medium and slow phases respectively. The rate constants obtained 
for Y58W Grx2 are as follows: for the fast phase 76 milliseconds, the medium 
phase 1.1 seconds and the slow phase 212 seconds with corresponding amplitude 
changes of 57 %, 22 % and 21 % respectively. 
 
The dependence of the amplitudes on urea concentration for all three refolding 
phases shows complex behaviour for both wild-type and Y58W Grx2 (Figure 17 
A). The figure representing the urea dependence is obtained by plotting the 
amplitudes for the fast, medium and slow phases of refolding, obtained from 
fitting the data to a triple exponential, against the final urea concentration of 
refolding. The changes in the amplitude dependence of the medium phase do not 
resemble those of the fast and slow phases. Rather the amplitude remains constant 
from 1 M urea to 1.8 M urea from which point it decreases to 2.6 M urea and then 
again remains constant from 2.6 M urea to 4 M urea. This pattern is a complex 
one, but is also seen to occur for the medium phase amplitudes of Y58W Grx2 
over the range of refolding urea concentrations. The slow phase amplitude, 
however increases for the entire range of urea concentrations although the 
increase becomes steeper from 1.8 M urea to 4 M urea than it is from 1 M urea to 
1.8 M urea. In an opposite manner, the fast phase amplitudes decrease from 1 M 
urea to 4 M urea with a steeper decrease occurring from 1.8 M urea to 4 M urea. 
The changes in amplitude over the range of urea concentrations, for the fast and 
slow phase are the same for the wild-type and mutant proteins with only the 
percentages increasing or decreasing for the fast and slow phases respectively 
between 1 M and 2.5 M urea. 
 
Amplitudes as well as rates for each phase of refolding are obtained from fitting 
the kinetic refolding data to a triple exponential. The log of the rates for both 
unfolding phases was plotted against the residual urea concentration at which 
refolding was conducted (Figure 17 B) giving the urea dependence of the rates.  
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Figure 17: Effect of varying final urea concentrations on refolding 
The (A) percentage amplitudes and (B) log of the rates of the () fast () 
medium and () slow phases of the respective refolding phases were plotted 
against the residual urea concentrations from 1 M to 4 M. Data for wild-type Grx2 
(closed symbols) and Y58W Grx2 (open symbols) were fitted as stated for Figure 
17. Linear regression analysis curves for the proteins are represented as follows: 
(—) wild-type Grx2 (medium phase all data and fast and slow phases from 1 M to 
2.2 M urea), (---) wild-type Grx2 (from 2.2 M urea to 4 M urea for the fast and 
slow phases). Then for (—) Y58W Grx2 (fast phase 1-3 M urea, the medium 
phase 1-2.6 M urea and the slow phase 1-2.2 M urea), and (—) Y58W Grx2 from 
3 M urea (fast phase) or 2.2 M urea (slow phase) to 4 M urea. See Table 4 for 
parameters.   
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Table 4: Affect of varying final urea concentration on refolding 
The logarithm of the rates of the fast medium and slow phases of refolding for different final urea concentrations for both wild-type and 
Y58W Grx2 are displayed in Figure 17. Linear regression analysis was done for subsections of the data sets for each phase and each protein. 
For the wild-type protein, the fast phase data were separated into two sections and regression analysis done for each section: 1 M to 2.2 M 
urea (R2=0.53) and 2.6 M to 4 M urea (R2=0.94). The medium phase data was fitted as a single set (R2=0.92) and the slow phase as for the 
fast phase with R2 values of 0.32 and 0.99 respectively. The mutant protein data were also analysed in subsections for all the phases of 
refolding. For the fast phase: 1 M to 3 M urea (R2=0.78) and 3.3 M urea to 4 M urea (R2=0.92). The medium phase only a subsection of the 
data could be fitted form 1 M urea to 2.6 M urea (R2=0.95). Then for the slow phase: 1 M to 2.2 M urea (R2=0.83) and 2.6 M to 4 M urea 
(R2=0.96). Fitting the data to a linear function results in obtaining the parameters of mf (change in solvent accessibility during refolding) and 
kf(H2O) (apparent refolding rate in the absence of denaturant) (Tanford, 1970), presented in this table . 
  
Wild-type Grx2 Y58W Grx2 Parameter 
 Fast phase 
 
Medium 
Phase 
Slow phase Fast phase Medium 
phase 
Slow phase 
Urea concentration 
range (M) 
1-2.2    2.5-4 1-4 1-2.2 2.5-4 1-3 3.3-4 1-2.6 1-2.2 2.5-4 
mf (kJ mol-1/ M urea) 0.25 (± 
0.17) 
0.69 (± 
0.12) 
0.84 (± 
0.10) 
0.10 (± 
0.10) 
1.2 (± 
0.071) 
0.47 (± 
0.12) 
1.9 (± 
0.40) 
0.52 (± 
0.068) 
0.24 (± 
0.076) 
1.2 (± 
0.12) 
kf(H2O) (s-1) 23 (± 1.9) 39 (± 4.1) 3.1 (± 0.69) 4.7 x 10-3 
(± 1.4 x 
10-4) 
0.11(± 
0.011) 
27 (± 2.0) 0.015 (± 
4.7 x 10-3) 
1.5 (± 0.42) 4.2 x 10-3 
(± 8.9 x 10 
-5) 
0.081 (± 
0.011) 
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Based on the points where changes in the urea dependence occur linear regression 
was done for sections of the data (See Figure 17 B and Table 4). The data were 
fitted to the following equation (Tanford, 1970): 
log kf=log kf(H20)+mf[Urea]                                       (16) 
where kf is the apparent first order rate constant for refolding. The mf values 
(change in solvent accessibility during refolding) and the apparent rates of 
refolding in the absence of water (kf(H2O)) reported in Table 4. The units for the 
mf values were determined by multiplying the values by the product of the gas 
constant (R = 8.31 J k-1 mol-1) and the temperature (298 K).  
 
The dependence of the rates of refolding on urea was shown to be complex for all 
phases of refolding for the mutant protein and for the fast and slow phases of 
refolding of the wild-type protein. The medium phase for the wild-type protein 
shows no changes in dependence over the range of urea concentrations while for 
the mutant protein this phase displays a change from 3.3 M urea to 4 M urea. Also 
the medium phase for wild-type and Y58W Grx2 (data from 1 M urea to 3.3M 
urea) show high urea dependence. The data for the medium phase for the mutant 
protein from 3.3 M urea to 4 M urea displays a complex dependence on urea in 
the upward direction. The fast and slow phases for wild-type Grx2 both show 
changes at 2.2 M urea in a downward direction although, the change for the fast 
phase is not as predominant as for the slow phase. This change at 2.2 M urea is 
also seen to occur for the slow phase of Y58W Grx2. At urea concentration of 1 
M to 2.2 M urea the slow phases of refolding for both proteins are urea 
independent and then from 2.2 M urea to 4 M urea the urea dependence increases. 
The fast phase for the wild-type protein also displays a more urea independent 
section for 1 M to 2.2 M urea, with the data from 2.2 M urea to 4 M urea 
displaying a higher urea dependence. For the mutant protein, the urea dependence 
is different to the wild-type protein for the fast phase with a change in the urea 
dependence occurring at 3.3 M urea to 4 M urea in an upward direction.  
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3.6 Double-jump refolding kinetic studies 
In order to uncouple the gross structural unfolding form the isomerization 
occurring during unfolding, a high denaturant concentration is required (Wallace 
and Matthews, 2002). At a high denaturant concentration, the slow urea 
independent isomerization will be kinetically separated from the rapid gross 
structural unfolding of the protein (Kiefhaber et al., 1992a). During unfolding, the 
fast phase occurs rapidly at 7.5 M urea with a time constant of 61 milliseconds for 
wild-type Grx2. With such rapid unfolding the refolding initiated from unfolding 
delays within the fast phase were not feasible. The rate of the fast phase however 
decreases with lower urea concentrations. Therefore, to optimize the kinetic 
separation of gross structural unfolding from isomerization as well as capture the 
rapidly unfolding species, lower urea concentrations were chosen (5.5 M and 6 
M). The time constants for the fast phase of unfolding are 28 sec and 12 sec at 5.5 
M urea and 6 M urea respectively. For both urea concentrations, a set of delay 
times were carried out with the resultant kinetics of refolding monitored by 
intrinsic tryptophan fluorescence as for single-jump refolding (see section 3.5).  
 
Different unfolded species created by the various initial urea concentrations as 
well as the different delay times of unfolding resulted in altered refolding kinetics. 
The final urea concentrations for the second jump or the refolding phase of the 
double-jump experiment were 0.9 M and 1 M urea for the 5.5 M urea and 6 M 
urea unfolding, respectively. Two sets of double-jump refolding experiments were 
therefore conducted. The first one involved the initial unfolding reaction in 5.5 M 
urea with varying delay times of unfolding before refolding was initiated in 0.9 M 
residual urea for a final protein concentration of 5 µM. The second set involved 
unfolding delays in 6 M urea before refolding was initiated by dilution of 
unfolding solution to produce refolding conditions of 1 M residual urea and 5 µM 
wild-type Grx2.  
 
  
 
71 
3.6.1 Double-jump refolding with unfolding delay in 5.5 M urea 
The unfolding of wild-type Grx2 in 5.5 M urea is composed of 2 phases, the fast 
and slow phase. The fast phase is complete in 50 seconds at 20ºC and from 50 
seconds, the slow phase of unfolding occurs. In order to refold fast and slow 
unfolded species the refolding reaction was initiated following 5 seconds of 
unfolding to 500 seconds unfolding for the double-jump experiment. Refolding of 
wild-type Grx2 following unfolding delays from 5 seconds to 45 seconds is only 
composed of two phases (Figure 18 A), a fast and medium phase. The delays of 
50 seconds (Figure 18 B) and longer are composed of three phases (fast, medium 
and slow). 
 
Although the refolding of equilibrium unfolded wild-type Grx2 is composed of 
three phases (see section 3.5.2) the slow phase amplitude is too small for proper 
detection and therefore cannot be fitted for refolding following unfolding delays 
of shorter than 50 seconds. The first time the data can be fitted to a triple 
exponential is for an unfolding delay of 50 seconds unfolding delay (Figure 18 
B). At a 500 seconds unfolding delay time, the refolding is the same as the 
refolding of equilibrium unfolded wild-type Grx2 (Figure 16 ; Figure 19). The 
baselines indicate that the refolding of the transiently unfolded wild-type Grx2 is 
complete (Figure 19) after 1000 seconds following 500 seconds unfolding delay 
time. For many of the short unfolding delay times including 10 seconds unfolding 
delay, a large burst phase is observed where a large amount of the refolding 
amplitude change occurs in the dead-time of the instrument (Figure 18 A).  
 
In order to identify trend in the changes that occur as the unfolding delay time 
increases the amplitudes (Figure 20 A) and rates of refolding (Figure 20 B) of the 
relative phases were plotted against the unfolding delay time for which they were 
obtained. The amplitudes and rates were obtained by fitting a double exponential 
(refolding traces for unfolding delays of 5 seconds to 45 seconds at 5.5 M urea 
unfolding) and a triple exponential (refolding traces for unfolding delays of 50 
seconds to 500 seconds at 5.5 M urea unfolding).  
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Figure 18: Double-jump refolding traces for unfolding delay in 5.5 M urea 
Refolding of 5 M wild-type Grx2 in 0.9 M residual urea following (A) 10 
seconds and (B) 50 seconds unfolding delay of 30 M wild-type Grx2 in 5.5 M 
urea. The refolding was monitored using intrinsic Trp fluorescence at 20 °C. For 
the 10 seconds and 50 seconds unfolding delay the first 4 seconds of recorded 
data were fitted to a double exponential. The refolding was complete by 4 seconds 
and no slow phase was observed for 10 seconds unfolding delay (inset) while an 
additional single exponential was fitted to the data for 50 seconds and longer 
delay times (inset). Data fitting was shown to be good by residuals plots. The 
arrows indicate the average baseline value for 5 µM native (black arrow) and 5 
µM urea denatured (blue arrow) wild-type Grx2.  
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Figure 19: Refolding following 500 sec unfolding delay in 5.5 M urea  
Average of three refolding trace of 5 µM of wild-type Grx2 in 0.9 M residual 
urea, pH 7 following unfolding delay of 500 seconds in 5.5 M urea at 20 ºC. 
Refolding was monitored by intrinsic Trp fluorescence and data were fitted to a 
tri-exponential function. This fit was shown to be a good by residuals plots. The 
slow phase (fitted to a single exponential function) occurs over 1000 seconds 
while the fast and medium phase are represented in the inset (fitted to a double 
exponential function) occur over 4 seconds. The average baseline value for 5 µM 
native (blue arrow) and denatured (black arrow) wild-type Grx2. 
 
 
 
  
 
74 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 20: Amplitude and rate changes for 5.5 M urea double-jump 
The () fast, () medium and () slow phase, (A) amplitudes and (B) log of the 
rates were plotted against the unfolding delay time. Refolding traces were 
obtained and fitted as described previously in this section 3.6.1 (also see Figure 
18 and Figure 19). The amplitudes displayed exponential changes (exponential 
fits indicted by solid black lines).  
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Overall changes in the amplitude data include a decrease in the fast phase 
amplitude with increasing unfolding delay time and an increase in both the slow 
phase and medium phase amplitude (Figure 20 A). The inability to detect the 
presence of a slow phase for short unfolding delay periods (5 to 45 seconds) does 
not support the presence of a lag in the development of the slow phase. Rather at 
the short unfolding delays it is expect that all the peptide bonds are in the native 
conformation and therefore there would be none to very few of the proteins 
passing through an isomerization phase to the native state. The trends in the 
amplitude data could be expressed mathematically and were fitted to single 
exponentials. Exponential decrease of the fast phase has a rate of 0.012 sec-1 (time 
constant of 85 seconds). The exponential increases for the medium and slow 
phases have rates of 0.0089 sec -1 (11 seconds time constant) and 0.061 sec -1(164 
seconds time constant), respectively. There is no corresponding trends for the 
rates of folding for all the refolding phases over the range of unfolding delay 
times (Figure 20 B). The only outlier for the rate data was that of the slow phase 
for the unfolding delay time of 50 seconds, this rate is faster because the slow 
phase here was fitted for a shorter time period than the other slow phases. 
 
3.6.2 Double-jump refolding with unfolding delay in 6 M urea 
A second double-jump experiment was conducted where unfolding in 6 M urea 
was allowed to occur for various delay times. These unfolding conditions were 
again selected in order to monitor the refolding of fast and slow unfolded species 
as well as avoid the 5.5 M urea unfolding region where changes in the unfolding 
occur (see section 3.5.1 and Figure 15). Similarly to the 5.5 M double-jump 
refolding traces obtained the refolding of transiently unfolded (6 M urea) wild-
type Grx2 displayed fast and medium phases of refolding only for short delay 
times. For delay times of 10 and 20 seconds the slow phase amplitude was too 
small to be detected and fitted in the refolding traces of wild-type Grx2 (Figure 21 
A). Refolding traces from 30 seconds to 50 seconds unfolding delay times showed 
a small slow phase and were fitted to a triple exponential (Figure 21 B).  
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Figure 21: Double-jump refolding traces for unfolding delay in 6 M urea 
Average (of three) refolding traces of 5 µM wild-type Grx2 in 1 M urea, pH 7 
following unfolding delay in 6 M urea. Traces for delay times of (A) 10 seconds 
and (B) 30 seconds are shown. Refolding was monitored at 20 ºC, by intrinsic Trp 
fluorescence. The 10 and 30 second data were fitted to a double exponential for 
the first 4 seconds of data and for the 30 second data only an additional single 
exponential (inset) was fitted for 4 to 50 second refolding trace data. The 
exponential fits are represented by solid lines and were shown to be good by the 
residuals plot. In A the inset shows that refolding is complete after 4 seconds 
(dark grey data is 4 second data and light grey 50 second refolding trace). The 
arrows indicate the average baseline value for 5 µM native (black arrow) and 5 
µM urea denatured (blue arrow) wild-type Grx2.  
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From 80 seconds unfolding delay to 500 seconds unfolding delay, the slow phase 
is present and fitted as for the single-jump refolding traces (Figure 22). At 500 
seconds unfolding delay the slow phase has an amplitude of 30 % and a rate of 
0.007 s-1 (time constant of 140 seconds).  
 
The slow phase of refolding develops from 20 seconds unfolding delay and the 
amplitude increases exponentially with increasing unfolding delay times (Figure 
23 A). As the slow phase of refolding increases with increasing unfolding delay 
times, the fast phase of refolding decreases exponentially (Figure 23 A). The 
medium phase amplitude remains independent of both the slow and fast phases 
and is constant from the 10 seconds unfolding delay time to the 500 seconds 
unfolding delay time in 6 M urea. The exponential increase of the slow phase and 
the decrease in the fast phase amplitude were both fitted to single exponential 
functions. The fast phase showed a decrease with a time constant of 76 seconds 
(rate of 0.013 sec -1). The slow phase had an exponential development with 
increasing unfolding delay time with a time constant of 100 seconds (rate of 0.010 
sec -1). In order to determine if changes occur to the rates of the refolding phases, 
the log of the rates was plotted against the delay time. Due to the slow phase 
having a small amplitude and occurring over a shorter time period for unfolding 
delay times of 30 seconds to 50 seconds, the rate would appear to have changed 
(Figure 23 B). This change in rate is however not a true reflection that a rate 
change has occurred due to the differences in fitting the slow phase data. There 
was no effect on the rates of the fast and medium phases. The slow phase does not 
display a lag but similarly to the 5.5 M double-jump data no trans isomers have 
formed for unfolding delay times shorter than 30 seconds. 
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Figure 22: Refolding following 500 seconds unfolding delay in 6 M urea 
Refolding trace for 5 µM Grx2 in 1 M residual urea, pH 7 recorded at 20 ºC, 
using intrinsic Trp fluorescence (inset first 4 seconds of refolding). The solid lines 
represent the exponential fits to the data (fitting show to be good by residuals 
plots). The slow phase fits a single exponential (main graph) while the fast and 
medium phases are shown in the inset fit to a double exponential. The arrows 
indicate the average baseline value for 5 µM native (black arrow) and 5 µM urea 
denatured (blue arrow) wild-type Grx2.  
 
 
Time (sec)
Fl
u
o
re
sc
en
ce
 
in
te
n
sit
y 
(vo
lts
)
-2.1
-2.0
-1.9
-1.8
-1.7
-1.6
-1.5
-1.4
-1.3
Time (sec)
0 200 400 600 800 1000
R
es
id
u
a
ls
-0.15
-0.10
-0.05
0.00
0.05
0.10
0.15
Time (sec)
Fl
u
o
re
sc
en
ce
 
in
te
n
sit
y 
(vo
lts
)
-2.6
-2.4
-2.2
-2.0
-1.8
Time (sec)
0 1 2 3 4
R
es
id
u
a
ls
-0.15
-0.10
-0.05
0.00
0.05
0.10
0.15
Fl
u
o
re
sc
en
ce
 
in
te
n
sit
y 
(vo
lts
)
R
es
id
u
a
ls
Fl
u
o
re
sc
en
ce
 
in
te
n
sit
y 
(vo
lts
)
R
es
id
u
a
ls
  
 
79 
 
Unfoldin delay time (sec)
0 50 100 150 200 250 300 350 400 450 500
A
m
pl
itu
de
0
20
40
60
80
100
Unfolding delay time (sec)
0 50 100 150 200 250 300 350 400 450 500
Lo
g 
k f
-2
-1
0
1
A
B
 
 
 
Figure 23: Amplitude and rate changes for 6 M urea double-jump  
The () fast, () medium and () slow phase, (A) amplitudes and (B) log of the 
rates were plotted against the unfolding delay time. Refolding traces were 
obtained and fitted as described previously in this section 3.6.2 (also seeFigure 21 
and Figure 22). The fast and slow phase amplitudes displayed exponential 
changes (exponential fits indicted by solid black lines).The medium phase data 
were fitted to a linear function.  
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3.7 Refolding experiments in the presence of hFKBP-12 
3.7.1 Double-jump refolding experiment in the presence of hFKBP-
12 
Refolding double-jump experiments were conducted in the presence of 1 µM 
hFKBP-12 a peptidyl-prolyl isomerase (PPI). Refolding double-jump experiments 
were conducted as described in 3.6.2 the only exception was that PPI, hFKBP-12 
was introduced in the refolding buffer. In the presence of the PPI an increases in 
the rate of the slow phase of refolding was observed (Figure 24). The time 
constants for the fast and medium phases of refolding, in the absence and 
presence of the PPI, were the same. There was no increase in the rate or catalysis 
of the reactions that are taking place during these folding events, but the slow 
phase shows an increase in rate in the presence of PPI. The increase in the rate 
can be seen by a clear decrease in the time constant (the inverse of the rate) 
(Figure 24). 
 
Amplitude changes observed in the absence of PPI (Figure 23 A) are the same as 
those observed in the presence (Figure 25) with the fast phase amplitude 
decreasing exponentially and the slow phase amplitude increased exponentially. 
The exponential increase in the slow phase indicated that the slow phase develops 
during unfolding with a time constant of 243 seconds (rate of 0.0041 sec-1). This 
is greater than for the double-jump refolding experiment in the absence of PPI. 
The higher time constant for the development of the slow phase may not be 
significant, as the data set is smaller for this experiment and therefore could 
change the fit of the exponential to the data. The fast phase decreases 
exponentially with a time constant of 71 seconds this is very similar as for the 
decrease in the fast phase in the absence of PPI (time constant of 77 sec).   
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Figure 24: Time constants for double-jump refolding in the presence of 
hFKBP-12 
The time constants obtained for the double-jump refolding in the presence of PPI 
for the fast (squares), medium (triangles), and slow (circles) phases. The refolding 
double-jump experiment was conducted as described previously (3.6.2) only 1 
µM hFKBP-12 was added to the refolding buffer for each unfolding delay time. 
The refolding of wild-type Grx2 in the presence (black symbols) and absence 
(Grey symbols) of the PPIase was monitored using intrinsic tryptophan 
fluorescence  at 20 °C (excitation 280 nm with emission monitored with a 320 nm 
cut off filter). The resultant refolding traces fit to a double (40 and 50 sec 
unfolding delays) and triple exponentials (unfolding delay times longer than 50 
sec).  
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Figure 25: Amplitudes for double-jump refolding in the presence of hFKBP-
12 
The refolding double-jump experiment was conducted and data fitted as described 
previously Figure 24. From the data the amplitude changes for the () fast, () 
medium and () slow phase of refolding in the presence of 1 µM hFKBP-12 are 
shown here. The fast phase and slow phase data were fitted to single exponential 
functions (solid lines).  
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3.7.2 Single-jump kinetic refolding in the presence of hFKBP-12 
The effect of the PPI, hFKBP-12 on the refolding kinetics of wild-type Grx2 was 
determined by conducting single-jump refolding experiments. Wild-type Grx2 
was allowed to unfold for at least an hour to allow the protein to unfold to 
equilibrium. Refolding of the equilibrium-unfolded protein was then initiated by 
dilution and monitored by intrinsic tryptophan fluorescence. PPI was added to the 
refolding buffer. There are no changes in the amplitudes of the respective three 
refolding phases (Figure 26 A). The fast phase maintains a 50 % amplitude, the 
medium phase a 20 % and the slow phase a 30 % amplitude. These values are 
consistent with those obtained for single-jump refolding (wild-type Grx2) for 1 M 
urea in the absence of PPI (Figure 17). Changes are however observed for the 
rates of the slow phase as the PPI concentration is increased. The slow phase was 
enhanced four fold when the final concentration of hFKBP-12 was 3 µM, there 
was however no affect on either the fast or the medium phases of refolding at this 
concentration of hFKBP-12 (Figure 26 B). A linear increase was observed with 
increasing hFKBP-12 concentration for the slow phase (slope of 1.1) of refolding, 
but no increase was observed for the fast and the medium phases (slopes of 0 and 
0.1 respectively) of refolding.  
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Figure 26: Refolding of wild-type Grx2 in the presence of hFKBP-12 
The (A) amplitudes of the refolding phases and (B) rate of the refolding phases in 
the presence (k) of the PPI divided by the rate of the same phase in the absence 
(ko) of PPI was plotted against hFKBP-12 concentration. The () fast, () 
medium and () slow phase data were plotted. Final refolding conditions: 5 µM 
wild-type Grx2 in 1 M urea with hFKBP-12 (concentration range 0 µM to 3 µM). 
The solid lines represent linear function fits to the data.  
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4 DISCUSSION 
4.1 Stability of Grx2 proteins  
Three Grx2 proteins were investigated in order to determine the unfolding and 
refolding pathways for Grx2. One of these proteins was wild-type Grx2 and then 
using the wild-type protein one protein was created by labelling a residue with 
AEDANS. The third protein was produced by the insertion of a local intrinsic 
probe (tryptophan residue) by mutagenesis. As the mutant protein was created to 
be identical to the wild-type protein in terms of stability and folding it should not 
show any changes in stability. Equilibrium unfolding studies were used to assess 
the stability of the proteins. Prior to these studies it was evident from the 
secondary and tertiary structural characterization of the mutant and AEDANS-
labelled protein that the mutant had similar structure to the wild-type but the 
labelled protein had been altered. The secondary structural nature of the 
AEDANS-labelled protein was distinctly denatured from that of the native 
unlabelled wild-type protein (see far-ultraviolet circular dichroism spectra wild-
type and AEDANS labelled protein Figure 8). The spectrum for the mutant 
protein indicates that AEDANS-labelled glutaredoxin loses the -helical nature 
that was present for the native unlabelled wild-type protein just as the wild-type 
protein does on unfolding.  
 
The mutant protein (Y58W) was expressed in high yield (70 mg protein per litre 
2XYT media, in comparison to wild-type which yielded 80 mg protein per litre 
2XYT media) as well as was found in the soluble cytoplasm fraction of whole 
cells (Figure 6), all indicating that the tryptophan mutant had not dramatically 
altered the stability of the mutant protein. The insertion of a tryptophan residue at 
a position that is normally occupied by a tyrosine residue should have minimal to 
no affect on the native protein because both residues have similar hydrophobicity 
values (Wolfenden et al., 1979) and average buried volumes (Chothia, 1975). 
Also Tyr58 is situated close to the surface of the protein in a slightly solvent 
exposed positions as is evident from and increase in the fluorescence intensity at 
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345 nm (Figure 9), a wavelength that was shown for the wild-type protein to 
represent the emission of slightly exposed tryptophan residues. 
 
Following the evidence that the secondary structure of AEDANS-labelled protein 
had been altered, the stability of the proteins was assessed by equilibrium 
unfolding studies. Data for wild-type Grx2, Y58W Grx2 and AEDANS-labelled 
Grx2 were all fitted to a single sigmoidal transition. The parameters of G(H2O) 
as well as the m-value and Cm for the transition region of unfolding are obtained 
from fitting the data to a sigmoidal transition (Table 2). The unfolding therefore 
for all three proteins was two-state, displaying a cooperative unfolding reaction.  
 
The G(H2O) value for the unfolding of a protein in the presence of water as 
extrapolated from the urea-induced unfolding indicates the conformational 
stability of the protein (Pace, 1986). The average G(H2O) values for all the 
spectroscopic probes obtained from fitting the single sigmoidal curve for native 
unlabelled protein, mutant protein and labelled protein are 12.3 kcal.mol-1, 9.5 
kcal.mol-1 and 5.4 kcal.mol-1 respectively. The G(H2O) values obtained for all of 
the Grx2 proteins is within the range stated for monomeric proteins (6 to 14 
kcal.mol-1) (Neet and Timm, 1994) although the decrease in conformational 
stability indicates that addition of AEDANS to Grx2 destabilizes the protein while 
mutagenesis resulting in the substitution of Tyr58 with Trp does not significantly 
destabilize the protein.  
 
As proteins unfold, there is an increased exposure of surface area. The m-value 
obtained from the sigmoidal fit gives an indication of the amount of surface area 
exposed during unfolding of a protein (Alonso and Dill, 1991; Myers et al., 
1995). The change in accessible surface area for wild-type Grx2 and Y58W Grx2 
was calculated to be 19088 Å2 using the following equations of Myers et al. 
(1995): 
(n x 93) – 907= ASA                                            (17)    
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 where n is the number of residues for the protein. The m-value for urea as 
denaturant can then be predicted based on the calculated change in accessible 
surface area: 
(ASA x 0.11) + 374 = m                                       (18) 
 Using this equation the predicted m-value for wild-type Grx2 and Y58W Grx2 is 
2.5 kcal mol-1 M-1 urea (Myers et al., 1995). This predicted value agrees well with 
the experimentally obtained m-values for both wild-type Grx2 and Y58W Grx2 
(Table 2). From these values it can be seen that the mutant exposes a similar 
amount of surface area as the wild-type protein and that the cooperativity of the 
unfolding reaction has also not been altered dramatically by the substitution of the 
Trp58 residue. The low m-value however, obtained for the unfolding of labelled 
Grx2 indicates that the protein has more exposed surface area in the native state 
than the unlabelled protein and therefore is destabilized by the modification with 
AEDANS. As the destabilized protein unfolds, less surface area is exposed as 
some is already exposed in the native folded structure. This result is consistent 
with the far-ultraviolet spectrum obtained for the native labelled protein that 
indicated that there was a loss of the proteins characteristic secondary structural 
elements due to the label. The cooperativity of the unfolding reaction for Y58W 
Grx2 has also decreased indicating that intermediates may be present during 
unfolding. The presence of intermediates in the unfolding pathway of the labelled 
protein is further confirmed by the lack of agreement of the parameters, obtained 
from the sigmoidal two-state fit, between the tertiary structural probes and the 
secondary structural probes. The lower m-values for all the probes used to 
monitor the unfolding of the labelled protein versus the two probes used to 
monitor the unlabelled protein indicate that there is more than one equilibrium 
state (Myers et al., 1995). This behaviour was not seen for the wild-type and 
Y58W Grx2 proteins, clearly indicating that the unfolding pathway as described 
by the equilibrium data is a two-state process with no intermediates. 
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The Cm value is the midpoint of the unfolding transition. The unlabelled protein 
has Cm value of 4.4 M urea, which is in agreement with the Cm value of the 
mutant protein (4.3 M). The Cm values for the labelled protein however much 
lower at 3.0 M urea. This indicates that lower amounts of denaturant are able to 
disrupt the labelled proteins structure. The Cm value for the labelled protein adds 
to the conclusion that the labelling of the protein has disrupted the native structure 
of Grx2. 
 
The conformational stability and structure of AEDANS-labelled Grx2 is 
decreased substantially compared to the wild-type protein therefore the labelled 
protein cannot be used to assess local changes that would occur at the active site 
region of domain 1. The mutant protein however showed no significant changes 
in stability or structure in comparison to the wild-type protein with the 
equilibrium data displaying a single sharp transitions as for wild-type Grx2 
(Figure 13). Changes in the rates for folding and unfolding can also indicate a 
change in the stability of a protein where amino acid substitutions have been 
conducted (Goldenberg, 1992). The rates of the slow unfolding phase as well as 
the three refolding phases of Y58W were not significantly altered in comparison 
to the wild-type protein [see section 3.5.1 (unfolding) and 3.5.2 (refolding) for 
rates] further indicating minimal changes in stability of Y58W Grx2 in relation to 
wild-type Grx2. The slight decrease in the stability of Y58W Grx2 (Table 2) is 
however reflected in the increased rate of the fast phase of unfolding of the 
mutant protein (see section 3.5.1).  
 
Y58W Grx2 and wild-type Grx2 display two-state highly cooperative equilibrium 
unfolding behaviour. This two-state unfolding behaviour has been identified for 
homologous dimeric GST family members such as Pi (Dirr and Wallace, 1999; 
Erhardt and Dirr, 1995) Schistosoma japonicum (Kaplan et al., 1997), and Alpha 
(Wallace et al., 1998; Wallace and Dirr, 1999) GST. Interestingly there are also 
examples of these homologues dimeric GST’s where the unfolding is multistate 
which can be attributed to in all cases a monomeric intermediate (Hornby et al., 
  
 
89 
2000; Hornby et al., 2002; Sacchetta et al., 1993; Stevens et al., 1998). There is 
however no evidence that the individual domains of the subunits fold 
independently. Rather there is a high degree of cooperativity between the domains 
for many of these GST proteins subunits (Erhardt and Dirr, 1995; Kaplan et al., 
1997; Hornby et al., 2000; Hornby et al., 2002; Luo et al., 2002; Stevens et al., 
1998; Wallace et al., 1998). It is possible from equilibrium studies to identify 
domains that denature independently as is the case for human  light chain (Rowe 
and Tanford, 1973). Based on the equilibrium data for Grx2 and the evidence of 
the structurally homologous GST proteins (Xia et al., 2001) it can be concluded 
that the domains of Grx2 do not fold independently and display a high degree of 
cooperativity. 
 
4.2 Unfolding of Grx2 
The conclusion drawn from the equilibrium unfolding data is that unfolding is a 
highly cooperative two-state process for Grx2. Based on this we would expect to 
have a single kinetic phase for unfolding with no intermediates. The kinetic 
unfolding of wild-type Grx2 and Y58W however is composed of two phases 
(Figure 14) as shown by the parameters obtained from fitting the data to a double 
exponential decay curve, assessed by a residuals plot to be a good fit. The 
dependence of the unfolding amplitudes as well as the rates of each phase is 
complex over the range of unfolding urea concentrations for wild-type Grx2 
(Figure 15). Both phases display a change in urea dependence of the rates of 
unfolding at 5.5 M urea and 5.6 M urea, for the fast and slow phases respectively. 
Changes in the urea dependence of unfolding have indicated the presence of 
intermediates in the unfolding of arc repressor (Jonsson et al., 1996). 
Intermediates are present in the unfolding of Ure2 a structurally related protein to 
Grx2 (Galani et al., 2002) and gene-3-protein (Martin and Schmid, 2003b). Both 
of these proteins display similar changes to those observed for Grx2, in the urea 
dependence of the rates and amplitudes of unfolding. These changes in amplitude 
over a range of denaturant concentration similar to those seen for wild-type Grx2 
(Figure 15 A) have been observed previously where it was concluded that at least 
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one intermediate was present during unfolding (Zaidi et al., 1997). The changes at 
5.5 M urea and 5.6 M urea (for the fast and slow phases respectively) were not 
detected for Y58W Grx2. Therefore intermediates formed during unfolding of 
Grx2 could involve structural elements in the local environment of Trp89 and 
Trp190 and not Trp58 as Trp 89 and Trp 190 are situated in the domain 2 of the 
protein (Vlamis-Gardikas, et al., 1997; Xia, et al., 2001) and Trp 58 has been 
inserted into domain 1.  
 
The slow phase of unfolding is urea independent (Figure 15 B) a characteristic 
which has been attributed to phases which involve proline peptide bond 
isomerizations (Kiefhaber et al., 1992a; Schmid and Baldwin, 1978). This phase 
also possesses a time constant of 140 sec, which is within the range for 
isomerization reactions (Brandts et al., 1975). The only Xaa-proline peptide bond 
in Grx2 that is in the cis conformation is the Val48-Pro49 peptide bond (Xia et 
al., 2001). This peptide bond will isomerise to the trans conformation as the trans 
conformation is favoured in the unfolded state (Brandts et al., 1975; Hinderaker 
and Raines, 2003). Many proteins however, that contain more than one cis-proline 
in the native state have simple unfolding kinetics, with only a single unfolding 
phase, such ribonuclease A (Dodge and Scheraga, 1996) and thioredoxin from 
Escherichia coli, a member of the same superfamily as Grx2 (Kelley and 
Stellwagen, 1984). Phases however, of unfolding that are isomerization phases 
can be detected for urea concentrations close to the transition region of unfolding 
and then disappear at higher urea concentrations (Brandts et al., 1975; Kiefhaber 
et al., 1992a; Kiefhaber and Schmid, 1992). This behaviour is not seen for Grx2 
as the slow phase maintains 20 % amplitude from 5.75 M urea to 7.5 M urea 
(Figure 15 A). Unfolding of staphylococcal nuclease A is biphasic with a slow 
isomerization phase with an amplitude of 90 % (Ikura et al., 1997). The slow 
phase of unfolding for Grx2 has an amplitude of 20 % under strong unfolding 
conditions. Unfolding phases that represents the major phase for low denaturant 
concentrations near to the transition region and then decrease with increasing 
denaturant concentration are said to represent cis-proline peptide bond 
isomerization events that are coupled to conformational folding events (Kiefhaber 
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et al., 1992a). The complex dependence of the amplitudes of the slow phase on 
urea concentration for wild-type Grx2 displays such behaviour so therefore this is 
a possible explanation for what is occurring during the slow phase of unfolding of 
Grx2. The complex dependence of the amplitudes and rates on urea concentration 
were not detected for the mutant (Y58W Grx2) and because Trp58 is situated in 
the local environment of the cis-Pro49 we would expect that changes due to the 
isomerization would be detected for the mutant. Alternatively the change in 
amplitude dependence from high amplitudes at low urea concentrations to low 
amplitudes at high urea concentrations for the wild-type Grx2 (Figure 15 A) could 
have shifted to lower urea concentrations for the mutant protein. The beginning of 
the increase in the slow phase amplitude with decreasing urea for the mutant 
protein is observed from 5.5 M to 5 M urea (Figure 15 A). The slow phase of 
unfolding for staphylococcal nuclease was also said to involve a proline 
isomerization (Kuwajima et al., 1991) but later it was shown that the curvature in 
the dependence of the rates of unfolding for this phase were due to the presence of 
an intermediate (Walkenhorst et al., 1997). An isomerization occurs during the 
slow phase of unfolding and there is the presence of intermediates during 
unfolding of Grx2 although it is not clear whether a parallel or sequential 
unfolding pathway exists. 
 
The mu values obtained by fitting equation 15 (Tanford, 1970) can be used to 
indicate solvent exposure during unfolding (Doyle et al., 1996). The mu values 
reported in Table 3 for wild-type and Y58W Grx2 indicate that the fast phase 
involves structural rearrangements that expose large amounts of surface area 
while the slow phase involves structural rearrangements that expose small 
amounts of surface area. Using the mu values obtained for the wild-type protein 
may not give an accurate description of the changes in surface area due to the 
complex dependence the rates show on the urea concentration and therefore the 
presence of intermediates (Doyle et al., 1996). The mu values for the mutant 
protein are still reliable and they agree well with the values for the smaller linear 
regions of the data that were fitted for the wild-type protein. It can therefore still 
be concluded that the unfolding of Grx2 involves the fast phase (a gross structural 
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unfolding phase) and the slow phase where only small rearrangements occur such 
as an isomerization with intermediates forming during unfolding, but do these 
phases represent a parallel or sequential unfolding pathway? 
 
Garel and Baldwin (1973) have demonstrated that fast and slow unfolding species 
coexist under unfolding conditions. An initial conditions test for unfolding 
conducted by Dr L. A. Wallace (unpublished data) demonstrated the presence of 
two native-like species that would result in two parallel unfolding pathways. 
Double-jump refolding experiments confirmed a parallel unfolding mechanism. 
No lag in the development of any refolding phase (Figure 20 A, Figure 23 A) 
indicates that at short unfolding delays there is still the presence of all the 
unfolded species necessary for refolding. For a sequential unfolding pathway 
when short unfolding delay times are used during a refolding double-jump 
experiment, only part of the sequential unfolding reaction would have taken place 
and then the additional unfolding reaction would be required to occur prior to 
refolding, resulting in a lag in the development of the refolding phase. Therefore, 
the most likely unfolding pathway is a parallel one for Grx2.  
 
4.3 Folding of Grx2  
The single-jump refolding kinetics for wild-type and Y58W Grx2 display three 
phases of refolding (Figure 16). Thioredoxin, a protein closely related to Grx2 in 
structure, was also show to have three refolding phases fast (0.54 seconds), slow 
(14 seconds) and slowest (500 seconds) (Kelley and Stellwagen, 1984). The order 
that the Grx2 refolding phases occur in as well as the identity of these phases was 
investigated. The urea dependence of the rates of the three phases of refolding for 
wild-type and Y58W Grx2 show complex behaviour, with a “roll-overs” 
(Baldwin, 1996) or changes in urea dependence occurring at certain urea 
concentrations. The complex urea dependence of all the refolding phases (Figure 
17 B) indicates the presence intermediates during folding. The detection of the 
folding intermediates for Grx2 are said to be early folding intermediates based on 
the position of the change in urea dependence at low urea concentrations (Zarrine
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Afsar and Davidson, 2004). The complete change in secondary structure 
formation for Grx2 occurs within the dead-time of the stopped-flow (Dr L A 
Wallace (unpublished data), this supports the conclusion of the formation of an 
early intermediates. Similar intermediates that are not due to the presence of 
isomerization of a peptide bond were detected for the structurally related 
thioredoxin protein (Georgescu et al., 1998). The structural similarity between 
Grx2 (Xia et al., 2001) and this protein is only for domain 1 of Grx2 and the 
entire structure of thioredoxin (Holmgren et al., 1975). In order to position the 
intermediates within a folding pathway it was necessary to identify if the folding 
pathway involves the parallel folding of protein along all three phases as well as 
what would create such heterogeneity of the unfolded state. 
 
4.4 Slow phase in Grx2 folding is an isomerization phase 
A bond isomerization requires a high energy of activation (20 kcal.mol-1) and 
therefore is a slower reaction with a time constant of 10 to 1000 seconds at room 
temperature (Brandts et al., 1975). The slow phase of refolding for wild-type and 
Y58W Grx2 have time constants of 180 seconds and 212 seconds respectively. 
These time constants fit into the range mentioned for bond isomerization. In 
general the slow phase of refolding can be attributed to an isomerization of an 
Xaa-proline peptide bond (Brandts et al., 1975; Kiefhaber et al., 1990; Schmid 
and Baldwin, 1978). The isomerization for Grx2 is presumably of the Val48-
Pro49 peptide bond, as it is the only Xaa-proline peptide bond in the cis 
conformation out of 12 proline residues, in the native protein (Xia et al., 2001). 
When a protein unfolds an equilibrium mixture is produced of both the cis and 
trans isomers. The isomers do not however have a 50:50 percent ratio rather the 
equilibrium is skewed (30:70 ratio cis:trans) and the trans conformation is 
favoured (Brandts et al., 1975; Schmid, 1992). Therefore a substantial proportion 
of the unfolded species are required to undergo isomerization to form the native 
protein. The slow phase of refolding accounts for only 30 percent of the 
amplitude change for the refolding of Grx2 at 1 M residual urea. This would 
indicate that only 30 percent of the unfolded species are in the trans 
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conformation. It has been shown that 90 to 70 percent of the unfolded species 
exist in the trans conformation (Schmid, 1992), therefore the amplitude for the 
isomerization phase of refolding should reflect this percentage. The percentage 
amplitude change does however increase to 80 % at a residual urea concentration 
increases to 3.9 M urea. Brandts et al. (1975) have demonstrated that under strong 
(un)folding conditions the amplitude of the isomerization phase can be greatly 
reduces and even absent. The amplitude of an isomerization phase has been 
shown to have a smaller amplitude at low denaturant concentrations and then 
develop an increase in amplitude as the urea concentration increases (Kiefhaber et 
al., 1992a; Kiefhaber and Schmid, 1992; Walkenhorst et al., 1997).  
 
The dependence of the slow phase amplitudes on urea is also relevant in the 
identification of this phase as the isomerization phase. The amplitude of slow 
phase of refolding increases with increasing urea concentration (Figure 17 A), this 
behaviour was shown to indicate a phase involved in isomerization for notch 
ankyrin domain (Mello et al., 2005). The amplitude of the slow phase for Grx2 is 
small at low concentrations of urea and then becomes the major phase as the urea 
concentration increases. This behaviour has been typically seen for phases where 
isomerization is coupled to conformational events (Kiefhaber et al., 1992a; 
Kiefhaber and Schmid, 1992). The slow phase could very well represent the 
isomerization of the cis-Pro49 as well structural refolding events but the 
denaturant dependence of the amplitudes of the isomerization phases are also said 
to occur due to the presence of rapidly forming intermediates. This has been 
shown to occur for ribonuclease T1 (Kiefhader et al., 1990), thioredoxin (Kelley 
et al., 1986) and lambda Cro repressor (Satumba and Mossing, 2002). The rates of 
all of the refolding phases displayed changes in urea dependence at various 
concentrations that was said to be due to the presence of intermediates (see 
section 4.3). The presence of intermediates during the refolding of Grx2 would 
also explain how the rate of the slow phase is relatively urea independent between 
1 and 2.2 M urea but then becomes highly urea dependent between 2.5 M urea 
and 4 M urea (Figure 17 B and for the mf values Table 4). The mf values obtained 
for all the phases of refolding indicate that for urea concentrations of 1 to 2.2 M 
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urea the slow phase is urea independent. Phases of refolding with rates that 
display urea independence are said due to this to involve proline isomerization 
(Kiefhaber et al., 1992a). 
 
The isomerization of the proline peptide bonds are slow steps in folding and 
therefore the development of the incorrect isomer during unfolding can be 
monitored by the double-jump refolding experiments (Brandts et al., 1975). 
Strong unfolding conditions are used so that unfolding proceeds more rapidly than 
isomerization (Wallace and Matthews, 2002). As the unfolding delay is increased, 
the amplitude of the isomerization phase will increase as more of the non-native 
isomer is formed during unfolding, requiring isomerization back to the native 
conformation during refolding. The amplitude of the isomerization phase of 
refolding will increase until equilibrium is reached between the species with 
different conformations of the Xaa-proline peptide bond. For wild-type Grx2 the 
slow phase amplitude increased exponentially (for both the 5.5 M and 6 M 
double-jump experiments) with increasing unfolding delay time. The exponential 
fitted to the development of the amplitude of the phase involved in isomerization 
gives the time constant for the formation of the slow folding species (Schmid, 
1986b; Wallace and Matthews, 2002). The time constant obtained from fitting the 
increase in slow phase amplitude with increased unfolding delay time is 100 
seconds and 164 seconds for the 6 M and 5.5 M urea double-jump experiments, 
respectively. These time constants are in agreement with that of the slow phase of 
unfolding (time constant of 140 sec) the potential isomerization phase. The 
medium phase also develops exponentially for the 5.5 M double-jump experiment 
(Figure 20) but the time constant (11 seconds) is rather small for an isomerization 
event as well as there is no development of this phase during the 6 M double-
jump experiment (Figure 23). Therefore, the evidence supports the conclusion 
that the slow phase of refolding involves the isomerization of the Val48-Pro49 
peptide bond. Double-jump experiments where isomerization phases were 
identified by the exponential increase of the amplitude of the isomerization phase 
with increasing unfolding delay time were conducted for thioredoxin (Bhutani 
and Udgaonkar, 2001) and pectate lyase C (Kamen and Woody, 2002). The 
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development of the isomerization phase amplitude for refolding double-jump 
experiments was not the only proof the phase was the isomerization of one Xaa-
Proline peptide bond in the cis conformation in the native protein, the 
enhancement of the phase by PPI was further confirmation (Kamen and Woody, 
2002). 
 
Further confirmation that the slow phase of refolding for Grx2 is the 
isomerization of the Val48-Pro49 peptide bond is the acceleration of this phase by 
the peptidyl prolyl isomerase (PPI), hFKBP-12. PPIs act as catalysts, accelerating 
the cis-trans isomerization of Xaa-proline peptide bonds (Fischer et al., 1984). 
Therefore, the phase with the enhanced rate in the presence of this catalyst must 
involve an isomerization event (Lang et al., 1987; Schreiber and Fersht, 1993). 
The amplitude meanwhile should not be affected at all (Lang et al., 1987; 
Schreiber and Fersht, 1993). When hFKBP-12 is added to the wild-type Grx2 
refolding buffers during single-jump refolding experiments the rate of the slow 
phase of refolding was enhanced 4-fold with 3 µM hFKBP-12. The rate of the 
medium and fast phases are unchanged and none of the amplitudes were affected 
by increasing amounts of the catalyst (Figure 26). The PPI was also introduced 
into the refolding buffer in a 6 M double-jump experiment. The results of the 
experiment indicated that the rate of only the slow phase of refolding was 
enhanced (Figure 24). This data indicates that the slow phase of refolding 
involves the isomerization in folding of Grx2. The amplitude for the slow phase 
remains unaffected by the presence of the PPI, for the double-jump (Figure 26), 
and single-jump experiments (Figure 26 A). The same percentage of unfolded 
species, therefore fold via the slow phase in the presence of the hFKBP-12 as in 
the absence of the hFKBP-12. Therefore, there is no channelling of folding 
species via the slow folding phase, in the presence of hFKBP-12. In the presence 
of PPI, an increase in the amplitude of the slow isomerization phase of folding of 
ribonuclease T1 was observed (Kiefhaber et al., 1990). The channelling of folding 
along defined kinetic routes in the presence of PPI has been shown to result in a 
higher yield of protein (Fransson et al., 1992). This does not occur for Grx2. 
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Borden and Richards (1990) concluded that the slow phase of refolding for 
thioredoxin from phage T4, was isomerization based on 3 observations; the 
denaturant independence, the time constant of the slow folding phase and the fact 
that slow refolding phase was dependant on dwell time or unfolding delay time 
during double-jump refolding experiments. Kamen and Woody (2002) concluded, 
based on evidence from double-jump experiments, catalysis of isomerization 
phases by cyclophilin (a PPI) and temperature studies, that for the folding of 
pectate lyase C, there are two slow phases of refolding that involve isomerization. 
Georgescu et al. (1998) also conclude that the slow phase in refolding of 
thioredoxin is the isomerization phase. A similar conclusion that the slow phase 
of refolding involves a cis-trans isomerization of a proline peptide bond can be 
made for Grx2 based on the evidence presented here. A summary of the evidence 
for the slow phase of refolding of Grx2 involving an isomerization are as follows: 
• A time constant of 180 seconds (which is within the range of 10 to 1000 
seconds at room temperature for phases said to involve Xaa-proline peptide 
bond isomerization (Brandts et al., 1975)) 
• The low urea dependence of the slow phase on urea concentration as well as 
the amplitude dependence behaviour (The amplitude of an isomerization 
phase has been shown to have a smaller amplitude at low denaturant 
concentrations and then develop an increase in amplitude as the urea 
concentration increases (Kiefhaber et al., 1992a; Kiefhaber and Schmid, 
1992; Walkenhorst et al., 1997)) (Figure 17 A and B) 
• The development of the slow phase with a time constant of 164 sec and 100 
sec with increasing unfolding delay times in 5.5 M and 6 M respectively, for 
double-jump refolding studies (Figure 20 A; Figure 23 A) 
• Acceleration of the rate of the slow phase of refolding only during single- 
and double-jump refolding studies by the PPI hFKBP-12 (Figure 24; Figure 
26 B) 
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The isomerization of the conserved cis-proline in the thioredoxin superfamily of 
proteins was shown to occur for thioredoxin in a compact intermediate structure 
during folding and does not hinder folding (Chaffotte et al., 1997; Cook et al., 
1979; Kiefhaber et al., 1992b). It has been shown in the folding of Grx2 that burst 
phase species are formed that possess native secondary structure that do not bind 
ANS (Dr L. A Wallace, unpublished data). This would indicate that the folding of 
Grx2 initially forms a very native-like structure, which would mean that the 
isomerization of the conserved cis-proline peptide bond would have to occur in a 
structure that posses large amounts of native secondary structure in a relatively 
compact native structural arrangement. As well as the region where the cis-
proline peptide bond is situated is proposed to be in a folding initiation site (to be 
discussed in section 4.6) which would form early in the folding of proteins. Other 
proteins that have been shown to fold prior to isomerization include pectate lyase 
C, where isomerization of a cis-proline peptide bond occurred in a folding 
intermediate and the urea dependence of the rates of the isomerization phase were 
shown to be urea dependent (Kamen and Woody, 2002). Although the slow phase 
is the isomerization phase the question still remains how does it fit into the 
folding pathway with the medium and fast phases of refolding.   
 
4.5 A parallel or sequential folding pathway for Grx2?  
The unfolding of Grx2 is biphasic indicating the presence of potentially maximum 
three unfolded species (Georgescu et al., 1998). While the isomerization about the 
Val48-Pro49 peptide bond would result in at least two unfolded species. Based on 
data presented here several potential folding pathways are proposed (Scheme 1, 
Scheme 2, Scheme 3 and Scheme 4). 
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For Scheme 1, Scheme 2 and Scheme 3, U1 would represent the unfolded protein 
with the Val48-Pro49 peptide bond in the cis conformation while U2 the trans 
conformation. I is the kinetically detected intermediate and N is the native state 
with the Val48-Pro49 bond in the cis conformation.  
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Scheme 1: Proposed folding scheme 1 for Grx2
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Medium Slow
U1
U2
NI
Scheme 2: Proposed folding scheme 2  for Grx2
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Scheme 3: Proposed folding scheme 3  for Grx2
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For Scheme 4, U1 and U2 would represent the unfolded protein with the Val48-
Pro49 peptide bond in the cis conformation while U3 the trans conformation. N is 
the native state with the Val48-Pro49 bond in the cis conformation 
 
 
Double-jump refolding experiments allowed the folding mechanism of Grx2 to be 
further dissected. A parallel versus a sequential folding mechanism of folding can 
be determined from the double-jump refolding data. Double-jump refolding 
experiments monitor changes that occur as unfolding of the protein proceeds to 
completion over time. The different species formed throughout the unfolding 
reaction can be “trapped” and their presence detected by the monitoring altered 
refolding kinetics. The unfolding reaction can results in a group of species that 
can fold along alternate parallel routes to the native state, or a group of unfolded 
species that can only fold along a single sequential pathway to the native state 
(Wallace and Matthews, 2002). The double-jump refolding experiments for Grx2 
showed an exponential development of the slow phase of refolding with an 
exponential decrease in the fast phase amplitude with increasing unfolding delay. 
A parallel folding pathway is proposed where unfolded species with the correct 
proline isomer fold during the fast phase to the native state and species with the 
incorrect isomer fold along the slow phase to the native state. The medium phase 
is not affected by the increase in unfolding delay and is constant from the shortest 
unfolding delay times for 6 M double-jump experiments, this indicates the phase 
is an independent pathway to the fast and slow pathways. The medium phase does 
show an exponential development for the 5.5 M double-jump experiment (Figure 
20) but the development has a time constant of 11 seconds and does not appear to 
be linked to the fast or slow phase’s changes in amplitude. The single-jump 
U1
U2
U3
Fast
Medium
Slow
N
Scheme 4: Proposed folding scheme 4  for Grx2
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refolding studies also point toward a parallel mechanism of folding for Grx2. 
Both the amplitude and rates dependence on urea shows that the fast and slow 
phases of refolding act in an opposite but linked way to those of the medium 
phase, which behaves independently of the fast and slow pathways. The rates for 
the fast and slow phases both show changes in urea dependence at 2.2 M urea 
while the medium phase does not show these changes (Figure 17 B). It has been 
shown that the percentage amplitude for a kinetic refolding phase represents the 
fraction of species that take part in that refolding phase (Hagerman and Baldwin, 
1976). For Grx2 the amplitude dependence on urea shows how when the fast 
phase amplitude decreases the slow phase increases, therefore species if they are 
not folding via the fast phase they fold via the slow phase. In addition, the 
medium phase amplitude changes show that when folding does not occur along 
the fast/slow route then they fold via the medium phase. An initial conditions test 
conducted for the refolding of Grx2 indicated the presence three unfolded species 
(Dr L. A. Wallace, unpublished data). The data all supports the folding pathway 
proposed in Scheme 4. In order to eliminate the folding mechanisms proposed in 
Schemes 1, Scheme 2 and Scheme 3 an unfolding double-jump experiment would 
have to be conducted. Thioredoxin however, folds via a parallel folding pathway 
(Georgescu et al., 1998; Kelley and Richards, 1987). The parallel folding pathway 
stemming from a number of unfolded forms was determined for thioredoxin based 
on evidence where the amplitude of the fast phase of refolding decreased the slow 
phase amplitude increases (Bhutani and Udgaonkar, 2001). Other proteins that 
have parallel folding pathways as a result of proline isomerization include 
staphylococcal nuclease (Ikura et al., 1997; Kuwajima et al., 1991), ribonuclease 
T1 (Kiefhaber et al., 1990) and ribonuclease A (Dodge and Scheraga, 1996; 
Houry and Scheraga, 1996; Juminaga et al., 1998; Schultz et al., 1992).  
 
A parallel mechanism of folding is the most likely mechanism of folding for 
Grx2. The fast and slow phases represent species that are separated by the 
difference in conformation about the Val48-Pro49 peptide bond. Species with the 
correct cis-peptide bond conformation fold via the fast phase of refolding and 
with the incorrect conformation the slow phase but there is no explanation as to 
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what accounts for the third phase the medium phase of refolding. What 
differences in the unfolded state result in the partitioning of species along the 
separate medium phase to the fast-slow route of folding? 
 
4.6 Do the two domains of Grx2 play a role in (un)folding? 
If the folding pathway for Grx2 involves the folding of three unfolded species of 
Grx2 along three parallel pathways to the native state and the slow and the fast 
phases, exist due to differences about the Val48-Pro49 peptide bond what results 
in the medium phase? Could the two domains of Grx2 (Xia, et al., 2001) be 
folding independently? Trp 89 and Trp 190 are situated in the domain 2 of the 
Grx2 protein (Vlamis-Gardikas, et al., 1997; Xia, et al., 2001) and therefore act as 
local tertiary structural probes during (un)folding of Grx2 when monitored using 
intrinsic tryptophan fluorescence. These residues however can only provide 
limited information on the changes occurring in domain 1. The labelling of one of 
the active site cysteine residues with an extrinsic probe AEDANS resulted in a 
loss of secondary structure and a decrease in stability of the protein (see section 
4.1) while Y58W Grx2 showed no significant changes in structure or stability (see 
section 4.1) and therefore could provided information on local changes occurring 
in domain 1. The kinetics of unfolding for the mutant protein still displayed two 
phases of unfolding as for the wild-type protein, with similar urea dependencies 
of the rates of unfolding (see mu values in Table 3) while the kinetics of refolding 
for the mutant protein also still displayed the wild-type proteins three refolding 
phases. Based on the data it would appear that local probes situated in the two 
domains of the protein are reporting the same folding behaviour for Grx2. A 
highly cooperative equilibrium unfolding transition and a disruption of the entire 
protein by a label within domain 1 of the protein would indicate that this two-
domain protein behaves as one single cooperative unit. The domains of Grx2 are 
held together mainly by hydrophobic contacts as well as a hydrogen bond 
between Glu112 and His8 as well as Asn33 (Xia et al., 2001). The hydrophobic 
nature of the interdomain contacts suggests that the two domains are not stable on 
their own, this was proven to be the case as neither domains has successfully been 
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purified in isolation (Vlamis-Gardikas et al., 1997). There is also reported 
cooperativity between the domains of the subunits of structurally related Alpha 
(Wallace et al., 1998), Sigma (Stevens et al., 1998), Pi (Erhardt and Dirr, 1995), 
Schistosomal japonicum (Kaplan et al., 1997) and Mu (Hornby et al., 2000; 
Hornby et al., 2002; Luo et al., 2002) GST. It has been shown that for proteins 
where the individual domains (un)fold independently there will be more than one 
unfolding transition for the equilibrium unfolding data with more than two species 
taking present during the unfolding transition (Pace 1986). The equilibrium 
unfolding transition for gene-3-protein, a protein that possesses two domains that 
unfold separately, contained two distinct transitions (Martin and Schmid, 2003a). 
The identification of a cooperative two-state equilibrium unfolding transition does 
not however exclude the existence of autonomous folding units (Peng and Wu, 
2000). Llinás and Marqusee (1997) discovered for T4 lysozyme that an 
autonomously folding unit existed even though the equilibrium unfolding data 
indicated that the process was a two-state one. If the domains are not responsible 
for the structural separation of Grx2 could there exist a separation not based on 
the domains?   
 
The work conducted to identify autonomously folding units for T4 lysozyme 
highlighted the importance of interactions with in such a unit (Llinás and 
Marqusee, 1997). Tight linkage between domains 1 and 2 and cooperative 
equilibrium unfolding was shown for a mutant monomeric GST (Thompson et al., 
2006). It was also concluded based on hydrogen deuterium exchange studies, for 
this monomeric GST, that a stable core of interaction exist between domains I and 
II of the monomer (Thompson et al., 2006). In order for elements from both 
domains to act as a single folding unit, the inter-domain contacts formed must 
form early in folding and be as well as play an important role. Studies involving 
helix 6 in human glutathione transferase P1-1, indicated that when mutations were 
created that disrupted contacts with helix 1 or residues of conserved motifs in the 
helix, the global stability of the protein was disrupted (Dragani et al., 1997; 
Stenberg et al., 2000). Helix 6 is said to determine the direction of the polypeptide 
chain during folding as well as act as a folding nucleus (Dragani et al., 1997; 
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Stenberg et al., 2000). The refolding of this close family member protein sheds 
some light on the folding of Grx2. Helix 8 of Grx2 is structurally equivalent to 
helix 6 in GST P1-1 and is situated between domain 1 and 2 of Grx2, it interacts 
with helix 1 in domain 1 (Figure 27). It could similarly act as a folding nucleation 
site as well as provide strong inter-domain interactions.  
 
If helix 8 does act as a folding initiation site with its position at the domain 
interface it can be assumed that any structural division of the Grx2 structure will 
not be by the separation of the domains, instead, two structural folding units could 
exist: unit x and unit y. The cooperativity between domains and the local probes 
(Trp80 and Trp190) reporting on distant changes in the structure during folding 
all point to a cooperative core folding region (unit x). The kinetics of refolding 
however point toward a second unit (unit y) generating the parallel medium 
refolding phase. Helix 8 for Grx2 is said to be part of the folding x unit, as it 
would provide the necessary communication between the local environments of 
Trp 89 and Trp190 with domain 1 and more specifically the cis-proline (Val48-
Pro49 peptide bond). This communication is seen when the wild-type protein 
without Trp 58 (Y58W Grx2) still reports the slow phase of refolding (Figure 16). 
There are also no changes in the urea dependence of the rates of refolding of the 
slow phase when the domain 1 Trp 58 probe is present (Figure 17).  
 
Val48-Pro49 peptide bond occurs on the bend prior to -strand 3 (Xia et al., 
2001). The slow phase reports on the isomerization of this peptide bond therefore 
-strand 3 must also be part of the x unit. -strand 3 is linked to -strand 1 (Figure 
27) as they are the equivalent -strands to 2 and 4 strands of thioredoxin. 2 and 
4 strands have been identified as a folding nucleus in Escherichia coli 
thioredoxin. It has also been shown that the -sheets are the core of folding for 
thioredoxin (Bhutani et al., 2003). The zipping together of these strands in 
thioredoxin to form a  sheet is said to be a nucleation reaction for folding of the 
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Figure 27: Structure of Y58W glutaredoxin 2  
Structure of wild-type Grx2 was obtained from the protein data bank (1g70) and 
viewed with Swiss PDB viewer (ver 3.7) (Guex and Peitsch, 1997), showing the 
two domains, domain 1 (dark blue) and domain 2 (pale blue). The Pro49 residue, 
which is in the cis conformation, is represented in green and the tryptophan 
residues are yellow. Tyr58 in the wild-type protein was mutated using the 
program software to a tryptophan residue. Then -strand 1 is purple, -strand 3 is 
pink and -helix 8 is orange.  
 
 
Trp 58
Trp 190
Trp 89
Pro 49
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protein (Tasayco et al., 2000). Therefore, -strand 1 is also part of the x unit of 
folding for Grx2. It is also interesting that the protein folding core of the 
structurally related proteins to Grx2 occur in the region of the -sheets in close 
proximity to the conserved cis-proline as it has been shown for ribonuclease A 
that often chain initiation or nucleation sites of folding exist about cis-proline 
peptide bonds (Dodge and Scheraga, 1996). The fast phase of refolding and the 
slow phase of refolding have been shown to be present due to different 
conformations about the Val48-Pro49 peptide bond, they are seen to be linked as 
shown by the refolding double-jump amplitude data (Figure 20 A, Figure 23 A). 
The slow phase represents the folding of the x unit of the Grx2 structure and 
because the slow phase is linked to the fast phase of refolding, the fast phase 
represents the folding of this x unit of the Grx2 structure too. An indication this of 
this comes from the amplitude changes for the single-jump refolding data (Figure 
17 A). Here the mutant protein amplitudes become more pronounced for only the 
slow and fast phases of refolding while the medium phase remains unchanged. 
The increased intensity arises from the additional probe (Trp58) as can be seen 
from the native protein spectra for the wild-type and mutant proteins (Figure 9). 
So the slow and fast phases of refolding must report on the structural changes in 
the region of Trp58 which based on its location appears to report on the x unit of 
folding. This leaves the medium phase reporting on structural changes of the y 
unit of Grx2 during folding. If a parallel refolding pathway exists the fast and 
slow phases could represent the unfolding of the x and y units of Grx2 structure 
respectively. Then an observation that might link the fast and slow phases of 
unfolding to the unfolding of the x and y units respectively is that the amplitude 
increases for the fast phase and decreases for the slow phase of Y58W Grx2 with 
respect to the wild-type protein (Figure 15 A). The 5.5 M double-jump data 
provides further evidence because as the amplitude for the slow phase increases at 
5.5 M urea unfolding (Figure 15 A) so we see changes in the medium phase of 
refolding (Figure 20 A). There are however no changes in the trend of the fast and 
slow phases of refolding with increased unfolding delay time in comparison to the 
6 M data (Figure 20 A; Figure 23 A). This indicates as more molecules unfold via 
the slow pathway or the y unit pathway (45 % amplitude for the slow phase for 
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single-jump kinetic unfolding at 5.5 M urea- Figure 15 A) the medium refolding 
phase has to develop or the y structural elements have to rearrange to refold to the 
native state via the medium phase. Therefore the 5.5 M urea may stabilize the y 
elements in a non-native structure (unfolded) requiring a rearrangement of the y 
elements prior to refolding and hence the development of the medium phase 
during the double-jump work.  
 
The idea that elements of secondary structure smaller than subdomains could 
form early folding intermediates was also shown by the renaturation of 
proteolytically cleaved fragments of proteins such as horse cytochrome c, which 
could associate forming secondary structure and tertiary contacts (Wu et al., 
1994). These early associated secondary structural elements were said to represent 
early folding intermediates. The nucleation-collision model for protein folding 
also indicates that secondary structural elements form and associate to form 
microdomains, these microdomains then associate to form mulitmicrodomains, 
which can represent intermediates (Karplus and Weaver, 1994). The association 
of the 1 and 3 strands in the folding of Grx2 could represent the formation of a 
microdomain. This microdomain may then interact via helix 8 or contacts with 
helix 8 to form mulitmicrodomains. Following the formation of the microdomain 
the structural details of which elements associate to form the x element or unit in 
the folding of Grx2 are not clear. Some elements of the structure have been 
putatively assigned as part of the x unit but the urea dependence of the refolding 
phases indicated that the tryptophan probes are monitoring changes for the x and 
y units of the Grx2 structure. The fast phase and medium phase both display 
changes in the dependence of the rates of refolding for Y58W Grx2 at roughly 3.3 
M urea (Figure 17 ) which are not seen for the wild-type protein. This could point 
to the Trp58 probe reporting on the y unit elements while we have identified this 
probe as reporting on x unit folding too. The evidence presented does however 
clearly indicate that the folding of Grx2 does not involve the independent folding 
of domain 1 and domain 2. The folding of Grx2 could be separated into two 
regions although the structural details of exactly all of the elements of the x unit 
of folding and the y unit of folding cannot be defined by the scope of this study. 
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Further hydrogen exchange mass spectroscopy work or NMR studies would have 
to be conducted in order to confirm exactly which areas of the protein are 
nucleation sites and confirm the presence of two folding units that are not the two 
domains of Grx2. A similar folding of the protein spectrin via two structural 
elements or units that are not defined by the domains has been demonstrated 
(Batey et al., 2006). Here tryptophan reporter probes situated in each of the 
protein domains showed similar refolding behaviour as reported here for Grx2. 
 
4.7 Can a final (un)folding pathway be assigned for Grx2? 
The unfolding and folding of Grx2 have been discussed and it is not possible to 
definitively assign a final unfolding and refolding pathway for Grx2. The data 
presented here does not allow for the complete assignment of the parallel 
(un)folding pathways due to the presence of two structural folding units. The 
discussion however has allowed for the proposal of an idea for an (un)folding 
pathway. Beginning with the unfolding half of the pathway the fast and slow 
phases of unfolding could arise due to the presence of the x and y elements or 
units of structure previously identified (see section 4.6) as well as differences 
about the Val48-Pro49 peptide bond (see section 4.2). The slow phase of 
unfolding represents potentially the unfolding for the y unit where only small 
changes in surface area (see Table 3 for mu values) are detected. This phase 
represents a coupling of the isomerization reaction and conformational unfolding 
(discussed in section 4.2). The unfolding of the x unit is via the fast phase and this 
unfolding reaction produces the largest exposure of surface area (see Table 3 for 
mu values). The presence of minimum two native species is supported by the 
initial conditions test of Dr L A Wallace (unpublished data). It appears that the 
separation of these two species is based on differences in cis and trans isomers as 
well as a structural component. Based on the evidence presented so far the most 
likely unfolding pathway for Grx2 is a parallel one with the fast and slow phases 
occurring in parallel. Similarly parallel refolding pathways arise due the presence 
of a mixture of unfolded species. Two of three potential species are separated by 
differences in the conformation about the Val48-Pro49 peptide bond (this results 
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in the fast and slow pathways) (discussed in section 4.5). The fast/ slow folding 
species are said to be separated from the medium folding species by the structural 
division between the x and y folding units respectively of the Grx2 structure 
(discussed in section 4.6). The urea dependence is higher for the medium phase 
and both the regions of the fast phase in comparison to the 1 M to 2.2 M region of 
the slow phase. Therefore these phases represent gross structural changes rather 
than small rearrangements such as isomerization reactions. Again, the assignment 
of the pathways to a parallel mechanism involving the structural units is not a 
definitive one. Further experimentation would be required to eliminate any other 
possible mechanisms and clarify the structural details of the folding units as well 
as undoubtedly assign links between species formed from unfolding reactions to 
species required for the parallel refolding pathways. The amplitude for the slow 
phase of unfolding is 20 % (7.5 M urea) would have to link to the medium phase 
of refolding (20 % at 1 M urea). The corresponding 80 % for the fast phase 
refolds via the fast / slow (50 % / 30 %) refolding phases, but how can the slow 
unfolding isomerization phase not be linked to the slow refolding isomerization 
phase? Also the different (un)folding species resulting in parallel pathways are all 
said to arise due to a structural separation and differences in conformation about 
the Val48-Pro49 peptide bond but why then is there only two unfolding pathways 
where three are required for refolding?  
  
Intermediates have been detected for both the unfolding (see section 4.2) and the 
refolding (see section 4.3) of Grx2. It has been debated if these intermediates 
represent on- or off- pathway structures during folding although a review by 
Roder and Colon (1997), concluded that they predominantly on-pathway 
structures which reduce the conformational space during folding. The presence of 
intermediates during the (un)folding of Grx2 and the fact that the slow phase of 
unfolding and refolding involves an isomerization coupled to structural folding 
(see section 4.2 and section 4.4) precludes the characterization of the transitions 
states for Grx2 (Schmid, 1992).  
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